Section 31

EurekaMag PDF full texts Chapter 30,454


Bembry J. 1984: Cerebro vascular smooth muscle culture 2 characterization of adrenergic receptors linked to adenylate cyclase. Life Sciences: 783-792
Ikbal, M.; Baltaci, V.; Oztas, S.; Sonmez, M.K.; Batat, I. 1996: Cerebro-Oculo-Facio-Skeletal syndrome in a 3 years old boy. European Journal of Human Genetics 4(Suppl 1): 122
Sasaki, K.; Gemba, H. 1993: Cerebro-cerebellar interactions For fast and stable timing of voluntary movement. Mano, N , Hamada, I , DeLong, M R International Congress Series; Role of the cerebellum and basal ganglia in voluntary movement 41-50
Kelly, R.M.; Strick, P.L. 1998: Cerebro-cerebellar loops are closed. Society for Neuroscience Abstracts 24(1-2): 1407
Maddison, J.E.; Watson, W.E.J.; Johnston, G.A.R. 1992: Cerebro-cortical tritiated CNQX binding in dogs with congenital portosystemic encephalopathy and control dogs. Molecular Neuropharmacology 2(3): 237-240
Schrander-Stumpel, C.; van der Meer, S.; De Die-Smulders, C.; Meinecke, P.; Rupprecht, E.; Maroteaux, P.; Schrander, J.; Fryns, J.P. 1996: Cerebro-costo-mandibular syndrome: a follow-up study with 6 patients. Genetic Counseling 7(1): 71-72
Nakamura, Y.; Yoshinaga, J.; Koduru, T.; Ono, K.; Sasaki, T.; Kikumoto, O.; Mantani, T.; Hikiji, A. 1996: Cerebro-hemokinetics in Binswangers disease in comparison with senile dementia of the Alzheimers type. Neurobiology of Aging 17(4 Suppl): S113
Hall, B.D. 1994: Cerebro-oculo-nasal syndromeverification of a new syndrome with 3 additional cases. Pediatric Research 35(4 Part 2): 92A
Piantanida, M.; Tiberti, A.; Plebani, A.; Martelli, P.; Danesino, C. 1993: Cerebro-reno-digital syndrome in two sibs. American Journal of Medical Genetics 47(3): 420-422
Lubetzki, C.; Dubard, T.; Suarez, S.; Katlama, C.; Turell, E.; Calvez, V. 1997: Cerebro-spinal fluid HIV load and AIDS dementia. Neurology 48(3 Suppl 2): A387-A388
Hoffman, M.; Sacco, R.L.; Mohr, J.P.; Buda, J. 1993: Cerebroappendicular embolism: simultaneous cerebral infarction and brachial plexopathy. Neurology 43(3 Part 1): 620-621
Inoue, S.; Yamazaki, M.; Okamura, T.; Toda, N. 1989: Cerebroarterial relaxation induced by human atrial natriuretic peptide and its relationship to vasodilator nerves. Japanese Journal of Pharmacology 49(Suppl): 298P
Kadyrova, T.K.; Mursakulova, A.N.; Akhundova, F.D.; Mamdedov, M.M. 1989: Cerebrocardial syndrome in vascular hyper and hypotension in pediatric age. Azerbaidzhanskii Meditsinskii Zhurnal 7: 44-48
Shipp, S. 1996: Cerebrocartography. Current Biology: Cb 6(11): 1360-1362
Feher, G.; Hudetz, A.G.; Weigle, C.G.; Knuese, D.; Kampine, J. 1995: Cerebrocortical capillary flow during systemic hypotension and intracranial hypertension. Pfluegers Archiv European Journal of Physiology 430(4 Suppl): R22
Schroeder, H.; Maelicke, A. 1992: Cerebrocortical cellular expression of nAChR protein in Parkinsons dementia. Biological Chemistry Hoppe-Seyler 373(10): 948
Kaufmann, W.E. 1992: Cerebrocortical changes in AIDS. Laboratory Investigation; a Journal of Technical Methods and Pathology 66(3): 261-264
Schmidt, P.; Wevers, A.; Maderspach, K.; Cserpan, E.; Cserphan, I.; Staak, M.; Kaeferstein, H.; Sticht, G.; Schroeder, H. 1996: Cerebrocortical delta-opioid receptor mRNA expression in morphine-addicts. Society for Neuroscience Abstracts 22(1-3): 823
Langley, K.C.; Bergson, C.; Ouimet, C.C. 1996: Cerebrocortical expression of the D-1 dopamine receptor and DARPP-32 in rat brain. Society for Neuroscience Abstracts 22(1-3): 827
Smith, J.J.; Hudetz, A.G.; Lee, J.G.; Bosnjak, Z.J.; Kampine, J.P. 1994: Cerebrocortical laser Doppler flow response to CO-2 Preserved after nitric oxide synthase inhibition in the rat?. Anesthesiology 81(3A): A690
Sherman, G.F.; Holmes, L.B. 1999: Cerebrocortical microdysgenesis is enhanced in c57BL/6J mice exposed in utero to acetazolamide. Teratology 60(3): 137-142
Brosnan Watters, G.; Wozniak, D.F.; Mcewen, M.; Olney, J.W. 1993: Cerebrocortical neurotoxicity and chronic memory impairment induced by MK-801 in the mouse. Society for Neuroscience Abstracts 19(1-3): 1134
Bacon, D.A.; Afifi, M.S.; Griebel, J.A.; Cohen, N.A.; Piantadosi, C.A.; Camporesi, E.M. 1989: Cerebrocortical oxygenation and ventilatory response during sustained isocapnic hypoxia. Anesthesiology 71(3A): A1097
Klusa, V. 1995: Cerebrocrast Neuroprotectant cognition enhancer. Drugs of the Future 20(2): 135-138
Philip, N.; Guala, A.; Moncla, A.; Monlouis, M.; Aymé, S.; Giraud, F. 1992: Cerebrofaciothoracic dysplasia: a new family. Journal of Medical Genetics 29(7): 497-499
Hagendorff, A.; Jung, W.; Vahlhaus, C.; Omran, H.; Pizzulli, L.; Luederitz, B. 1995: Cerebrogenic arrhythmias and their correlation to increase of intracranial pressure and to decrease of cerebral blood flow. European Heart Journal 16(ABSTR Suppl ): 408
Burtsev, E.M. 1993: Cerebrogenic cardiac arrhythmias. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 93(6): 93-97
Oppenheimer, S.M.; Cechetto, D.F.; Hachinski, V.C. 1990: Cerebrogenic cardiac arrhythmias. Cerebral electrocardiographic influences and their role in sudden death. Archives of Neurology 47(5): 513-519
Ivins, J.K.; Litwack, E.D.; Kumbasar, A.; Stipp, C.S.; Yang, A.; Lander, A.D. 1995: Cerebroglycan and glypican are cell surface heparan sulfate proteoglycans expressed on axons and growth cones in the developing rat nervous system. Society for Neuroscience Abstracts 21(1-3): 795
Olenicheva, E.; Krasnov, V.; Yurkin, M.; Krjujov, V.; Kosterina, E. 1997: Cerebrolysin for psycho-organic syndrome early stages. European Psychiatry 12(Suppl 2): 197S
Kontzevoy, V.; Andrushenko, M.; Medvedev, A.; Sheshenin, V. 1997: Cerebrolysin in neuroleptic complications. European Psychiatry 12(Suppl 2): 212S
Vilenskii, B.S. 1997: Cerebrolysin in the neurologic and psychiatric practice. Likars'ka Sprava 1997(6): 139-142
Windisch, M.; Fruehwirth, M.; Grygar, E.; Hutter Paier, B. 1997: Cerebrolysin normalizes MAP2 homeostasis after glutamate induced neuronal cell death. Journal of the Neurological Sciences 150(Suppl ): S200
Allegranza, A.; Ferraresi, S.; Bruzzone, M.; Giombini, S. 1991: Cerebromeningeal pleomorphic xanthoastrocytoma. Report on four cases: clinical, radiologic and pathological features. (Including a case with malignant evolution). Neurosurgical Review 14(1): 43-49
Robbins, R.C.; Balaban, R.S.; Swain, J.A. 1989: Cerebroplegia protects the brain during two hours of circulatory arrest. Surgical Forum 40: 266-267
Loesel, W.; Roos, O.; Arndts, D.; Kuhn, F.J.; Strelle, I. 1997: Cerebroprojection method. Official Gazette of the United States Patent and Trademark Office Patents 1202(2): 1371-1372
Shiga, Y.; Shimada, F.; Fukui, Y.; Kawazura, H. 1997: Cerebroprotective effect of MS-153 after reperfusion or permanent focal ischemia in the rat. Japanese Journal of Pharmacology 73(Suppl 1): 245P
Paroczai, M.; Gere, A.; Karpati, E.; Kiss, B. 1993: Cerebroprotective effect of a new antioxidant agent, RG-107710. Mozsik, G, Emerit, I, Feher, J, Matkovics, B, Vincze, A Oxygen free radicals and scavengers in the natural sciences: 259-266
Smith, S.E.; Meldrum, B.S. 1994: Cerebroprotective effect of lamotrigine after focal cerebral ischaemia in the rat. British Journal of Pharmacology 111(Proceedings Suppl JAN ): 91P
Kurihara, J.; Ochiai, N.; Aoki, D.; Ogouchi, M.; Kato, H. 1993: Cerebroprotective effect of nicorandil in canine model of transient global cerebral ischemia. Japanese Journal of Pharmacology 61(Suppl 1): 210P
Aoki, Y.; Ukai, Y.; Kitano, M.; Kimura, K. 1998: Cerebroprotective effects of NS-7, a novel Na+- and Ca2+-channel blocker, in rats with transient occlusion of middle cerebral artery. Japanese Journal of Pharmacology 79(Suppl 1): 257P
Aoki, Y.; Shibahara, R.; Itoh, Y.; Ukai, Y.; Yoshikuni, Y.; Kimura, K. 1997: Cerebroprotective effects of NS-7, a novel pyrimidine derivative, in rats after permanent middle cerebral artery occlusion. Japanese Journal of Pharmacology 73(Suppl 1): 90P
Richer, C.; Vacher, E.; Fornes, P.; Clozel, J.P.; Giudicelli, J.F. 1996: Cerebroprotective effects of a calcium antagonist, mibefradil, in the stroke-prone spontaneously hypertensive rat. Fundamental and Clinical Pharmacology 10(2): 212
Van Brummelen, P.; Veniant, M.; Clozel, J.P. 1992: Cerebroprotective effects of ace inhibitors. Van Zwieten, P A , G Mancia And O E Brodde (Ed ) Royal Society Of Medicine Services Limited International Congress And Symposium Series, No 191 Hypertension, Atherosclerosis And Lipids; Workshop, Amsterdam, Netherlands, November 29, 1991 X+94p Royal Society Of Medicine Services Ltd : London, England, Uk; New York, New York, Usa Illus Paper 89-94
Smith, S.E.; Meldrum, B.S. 1992: Cerebroprotective effects of gyki 52466 1 4 aminophenyl 4 methyl 7 8 methylenedioxy 5h 2 3 benzodiazepine after focal ischaemia in the rat. British Journal of Pharmacology 105(Proceedings Suppl APRIL): 21P
Kuluz J.; Gregory G.; Yu A.; Chang Y.; Eng L. 1991: Cerebroprotective effects of intraischemic brain cooling in rats. Journal of Neurochemistry 57(Suppl): S69
Fluharty, A.L.; Espinosa De Los Monteros, A.; Fluharty, C.B.; De Vellis, J. 1994: Cerebroside sulfate uptake and hydrolysis by cultured glial cells. International Journal of Developmental Neuroscience 12(Suppl 1): 96
Goodrum, J.F. 1998: Cerebroside, unlike cholesterol, is not conserved during degeneration of sciatic nerve. Journal of Neurochemistry 70(Suppl 1): S34
Royal, W.I.; Gajewski, C.D. 1996: Cerebrospinal and blood levels of a retinol transport protein, transthyretin, in HIV-1 infection. INFECTIOUS DISEASES SOCIETY OF AMERICA Author, NATIONAL INSTITUTES OF HEALTH Author, CENTERS FOR DISEASE CONTROL and PREVENTION Author 3rd Conference on retroviruses and opportunistic infections : 143
Tamimi, W.; Al-Kharji, N.H.; Alanazi, M.; Felimban, N.; Al-Khulif, A.; Alharbi, K.K. 2008: Cerebrospinal creatinine kinase level in children with meningitis. Clinical Biochemistry 41(12): 1025-1027
Bada, H.S.; White, R.P.; Leffler, C.W. 1989: Cerebrospinal eicosanoids in posthemorrhagic hydrocephalus. Clinical Research 37(1): 64A
Mohammed, E.E.; Sulaiman, K. 1992: Cerebrospinal fistula following a penetrating spinal injury. Injury 23(2): 142
Candito, M.; Durant, J.; Gurle, V.; Chambon, P.; Dellamonica, P. 1995: Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in AIDS dementia complex. Aids 9(9): 1100-1101
Jensen, M.; Blomberg, M.; Engvall, B.; Hartmann, T.; Ida, N.; Beyreuther, K.; Basun, H.; Wahlund, L.O.; Lannfelt, L. 1997: Cerebrospinal fluid A-beta-40 is decreased and A-beta-42 is increased in subjects with mild to moderate Alzheimers disease. Society for Neuroscience Abstracts 23(1-2): 2235
Henneberg, A.E.; Link, D.; Bittmann, H.; Wollinsky, K.H. 1994: Cerebrospinal fluid Always a useful tool for immunological studies of CNS diseases?. Periodicum Biologorum 96(3): 257
Henneberg, A.E.; Link, D.; Bittmann, H.; Wollinsky, K.H. 1995: Cerebrospinal fluid Always a useful tool for immunological studies of central nervous system disease?. Regional Immunology 6(5-6): 358-360
Fuchs, S.A.; De Barse, M.M.J.; Scheepers, F.E.; Cahn, W.; Dorland, L.; de Sain-van der Velden, M.G.; Klomp, L.W.J.; Berger, R.; Kahn, R.é S.; de Koning, T.J. 2008: Cerebrospinal fluid D-serine and glycine concentrations are unaltered and unaffected by olanzapine therapy in male schizophrenic patients. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 18(5): 333-338
Tashima, K.T.; Caliendo, A.M.; Ahmad, M.; Gormley, J.M.; Flanigan, T.P.; Fiske, W.D. 1998: Cerebrospinal fluid HIV-1 RNA levels and efavirenz concentrations in patients enrolled in clinical trials. Journal of Neurovirology 4(3): 368
Brew, B.J.; Pemberton, L.; Cunningham, P.; Law, M. 1996: Cerebrospinal fluid HIV-1 RNA levels correlate with AIDS D ementia complex. ELEVENTH INTERNATIONAL CONFERENCE ON AIDS Author Eleventh International Conference on AIDS, Vol One One world: One hope : 24
Ahmad, M.; Tashima, K.T.; Flanigan, T.P. 1998: Cerebrospinal fluid HIV-1 RNA levels in cryptococcal meningitis. Journal of Neurovirology 4(3): 338
Ahmad, M.; Tashima, K.T.; Flanigan, T.P. 1998: Cerebrospinal fluid HIV-1 RNA stability at -4 degrees C. Journal of Neurovirology 4(3): 338
Hirohata, S.; Isshi, K.; Oguchi, H.; Haraoka, H.; Takeuchi, A.; Hashimoto, T. 1995: Cerebrospinal fluid IL-6 activity in patients with progressive neuro-Behcets syndrome. Arthritis and Rheumatism 38(9 Suppl): S271
Kanai, M.; Matsubara, E.; Igeta, Y.; Tomidokoro, Y.; Ishiguro, K.; Kawarabayashi, T.; Watanabe, M.; Shizuka, M.; Nakamura, T.; Okamoto, K.; Hirai, S.; Shoji, M. 1996: Cerebrospinal fluid TAU and beta-amyloid 1-40/42 in Alzheimers disease. Society for Neuroscience Abstracts 22(1-3): 1169
Mecocci, P.; Cherutini, A.; Bregnocchi, M.; Chionne, F.; Cecchetti, R.; Arnone, F.; Senin, U. 1997: Cerebrospinal fluid TAU protein in the diagnosis of old-age dementias. Society for Neuroscience Abstracts 23(1-2): 2173
Litvan, I.; Berrettini, W.; Atack, J.R.; Sunderland, T.; May, C.; Chase, T.N. 1990: Cerebrospinal fluid acetylcholinesterase galanin and neuropeptide y levels in progressive supranuclear palsy. Neurology 40(4 Suppl 1): 438
Ellis, R.J.; Spector, S.A.; Hsia, K.; Grant, I.; Mccutchan, J.A.len 1998: Cerebrospinal fluid acts as an independent viral dynamic compartment in some subjects with HIV-1 infection initiating combination antiretroviral therapy. Neurology 50(4 Suppl 4): A248
Alper, G.; Small, S.L. 1996: Cerebrospinal fluid after organ transplantation. Transplantation Proceedings 28(5): 2970-2973
Zdziarska, B.; Nowacki, P.; Millo, B. 1996: Cerebrospinal fluid albumin, beta-2 microglobulin, transthyretin and albumin CSF/serum quotient in patients with high-grade malignancy lymphoma or acute lymphoblastic leukemia Effect of intrathecal methotrexate prophylaxis. Annals of Hematology 73(Suppl 2): A138
Bernanke, D.; Shiota, T. 1996: Cerebrospinal fluid altered lattice compaction in a cerebral vasospasm model A role for protein kinase C?. FASEB Journal 10(3): A609
Kapaki, E.N.; Zournas, C.P.; Segdistsa, I.T.; Xenos, D.S.; Papageorgiou, C.T. 1993: Cerebrospinal fluid aluminum levels in Alzheimer's disease. Biological Psychiatry 33(8-9): 679-681
Butterworth, R.F.; Swain, M.; Bergeron, M.; Blei, A.T. 1990: Cerebrospinal fluid amino acid changes in relation to neurological status in acute liver failure studies in freely moving rats with in dwelling cisterna magna catheters. Hepatology 12(4 Part 2): 857
Gerrits, G.P.; Monnens, L.A.; Gabreëls, F.J.; De Abreu, R.A.; Koster, A.; Trijbels, J.M. 1993: Cerebrospinal fluid amino acids, purines and pyrimidines as a tool in the study of metabolic brain diseases. Journal of Inherited Metabolic Disease 16(4): 670-675
Bulat, M. 1996: Cerebrospinal fluid and brain Basic controversies and new vistas. Periodicum Biologorum 98(1): 11-15
Wiley, C.A.; Spector, S.A.; Ellis, R.; Achim, C.L.; Hsia, K.; Masliah, E.; Nelson, J.; Atkinson, J.H.; Grant, I.; (Usa), H.G.oup 1997: Cerebrospinal fluid and brain HIV load in AIDS. Brain Pathology 7(4): 1257
Soubeyrand, J.; Niamkey, E.; Tea, D.; Abissey, A.; Malet, B.; Leleu, J.P.; Kadjo, K.; Diallo, D.; Adom, H.; Beda, B.Y. 1989: Cerebrospinal fluid and human immunodeficiency virus. Semaine des Hopitaux 65(46): 2781-2786
Chalmers, A.C.; Aprill, B.S.; Shephard, H. 1990: Cerebrospinal fluid and human immunodeficiency virus. Findings in healthy, asymptomatic, seropositive men. Archives of Internal Medicine 150(7): 1538-1540
Petraitiene,R.; Petraitis,V.; Hope,W.W.; Mickiene,D.; Kelaher,A.M.; Murray,H.A.; Mya-San,C.; Hughes,J.E.; Cotton,M.P.; Bacher,J.; Walsh,T.J. 2008: Cerebrospinal fluid and plasma - beta -D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis. Antimicrobial Agents And Chemotherapy: 11, 4121-4129
Cinque, P.; Bestetti, A.; Carrera, P.; Pierotti, C.; Boeri, E.; Presi, S.; Racca, S.; Morelli, P.; Lazzarin, A. 1998: Cerebrospinal fluid and plasma HIV-1-RNA loads and genotypic resistance to reverse transcriptase and protease inhibitors in patients receiving triple drug combination therapy. Journal of Neurovirology 4(3): 345
Fekete, M.; Decsi, T.; Adamovich, K.; Szasz, M.; Pinter, Z. 1993: Cerebrospinal fluid and plasma amino acid levels in pathological newborn infants. Acta Paediatrica Hungarica 33(1-2): 3-12
Weiner, M.F.; Speciale, S.G.; Risser, R.C.; Kramer, G.L.; Petty, F. 1996: Cerebrospinal fluid and plasma gamma-aminobutyric acid in Alzheimer's disease. Biological Psychiatry 40(9): 933-934
Tumani, H.; Shen, G.; Tourtellotte, W.W. 1995: Cerebrospinal fluid and serum analysis in patients with optic neuritis Prevalence of cytokines, intrathecal IgG and viral antibodies and blood-CSF barrier function. Journal of Investigative Medicine 43(Suppl 2): 294A
Degiorgio, C.M.; Rabinowicz, A.L.; Gott, P.S.; Smith, T.; Heck, C.; Loskota, W.; Correale, J. 1996: Cerebrospinal fluid and serum neuron specific enolase in generalized convulsive, complex partial, and myoclonic status epilepticus. Neurology 46(2 Suppl): A356
Kazemi, H. 1991: Cerebrospinal fluid and the control of ventilation. Crystal, R G And J B West (Ed ) The Lung: Scientific Foundations, Vols 1 And 2 Xxxix+1207p (Vol 1); Xxxix+1016p (Vol 2) Raven Press: New York, New York, Usa Illus 1359-1368
McRae, A.; Dahlström, A. 1992: Cerebrospinal fluid antibodies: an indicator for immune responses in Alzheimer's disease. Research in Immunology 143(6): 663-667
Fazzini, E.; Fleming, J.; Fahn, S. 1990: Cerebrospinal fluid antibodies to coronaviruses in patients with parkinsons disease. Neurology 40(4 Suppl 1): 169
Liuzzi, G.M.; Mastroianni, C.M.; Jirillo, E.; Vullo, V.; Delia, S.; Riccio, P. 1990: Cerebrospinal fluid antibodies to two different forms of myelin basic protein as a marker of myelin damage in aids dementia complex. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Fb421
Sato, Y.; Hachiya, N.; Kuno, H.; Asoh, T.; Oizumi, K. 1998: Cerebrospinal fluid atypical lymphocytes in Japanese encephalitis. Journal of the Neurological Sciences 160(1): 92-95
Mahony, D.H.Jr; Gilllette, N.; Steuber, C.P.; Fernbach, D.J. 1990: Cerebrospinal fluid atypical pleocytosis implications for central nervous system leukemia relapse. Clinical Research 38(4): 973A
Perrella, O.; Izzo, E.; Liberti, A.; Gnarini, R.; Morisco, E.; Arciello, G.; Piccolo, F.; Soscia, M. 1990: Cerebrospinal fluid beta 2 microglobulin and ab hiv p24 in patients with aids. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Fb390
Marra, R.; Maussier, M.L.; Pagano, L.; Valenza, V.; Storti, S.; D'errico, G.; Mezza Botta, M.; Leone, G. 1992: Cerebrospinal fluid beta-2-microglobulin in acute lymphoid leukemia Comparison between RIA and DELFIA. Acta Medica Romana 30(3-4): 375-377
Britton, C.B.; Cote, L.; Altstiel, L. 1989: Cerebrospinal fluid biogenic amine metabolites in patients with aids. Neurology 39(3 Suppl 1): 380
Naini, A.; Nygaard, T.G.; Hirsch, O.; Moskowitz, C.B.; Levine, R.A.; Fahn, S.; Przedborski, S. 1995: Cerebrospinal fluid biopterin in disorders causing juvenile dystonia-parkinsonism. Neurology 45(4 Suppl 4): A430
Makoroff, K.L.; Martin, J.M.; Wald, E.R. 1997: Cerebrospinal fluid cell counts in infants lt 60 days of age. Pediatric Research 41(4 Part 2): 223A
Mcarthur, J.C.; Mcarthur, J.H.; Farzadegan, H.; Selnes, O.A.; Margolick, J.; Multicent Aids Cohort Study (Usa) 1989: Cerebrospinal fluid changes in hiv seropositive individuals correlation with declining cd4 counts. Neurology 39(3 Suppl 1): 379
Allegaert, K.; Scheers, I.; Adams, E.; Brajanoski, G.; Cossey, V.; Anderson, B.J. 2008: Cerebrospinal fluid compartmental pharmacokinetics of amikacin in neonates. Antimicrobial Agents and ChemoTherapy 52(6): 1934-1939
Torre, D.; Zeroli, C.; Issi, M.; Fiori, G.P.; Ferraro, G.; Speranza, F. 1991: Cerebrospinal fluid concentration of fibronectin in meningitis. Journal of Clinical Pathology 44(9): 783-784
Okwuasaba, F.K.; Ekwenchi, M.; Binitie, P. 1989: Cerebrospinal fluid concentration of ketanserin in monkeys and a subarachnoid haemorrhage patient. Medical Science Research 17(21): 907-910
Grimes, M.A.; Cameron, J.L.; Fernstrom, J.D. 1998: Cerebrospinal fluid concentrations of large neutral amino acids and monoamine metabolites in Macaca mulatta Effects of single high protein meals and venous infusions. American Journal of Physical Anthropology (Suppl 26): 88-89
Pokrajac, M.; Brzakovic, B.; Levic, Z.; Varagic, V.M. 1996: Cerebrospinal fluid concentrations of phenobarbital in patients with status epilepticus The comparison with seizure-free patients. Electroencephalography and Clinical Neurophysiology 99(4): 326
Dobbie, M.; Crawley, J.; Waruiru, C.; Marsh, K.; Surtees, R. 1997: Cerebrospinal fluid concentrations of quinolinic acid, total neopterin and nitrate plus nitrite in Kenyan children recovering from cerebral malaria. Journal of Neurochemistry 69(Suppl ): S181
Pitts, A.F.; Samuelson, S.D.; Meller, W.H.; Bissette, G.; Nemeroff, C.B.; Kathol, R.G. 1995: Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls. Biological Psychiatry 38(5): 330-335
Brew, B.J.; Bhalla, R.B.; Fleisher, M.; Schwartz, M.K.; Price, R.W. 1989: Cerebrospinal fluid csf beta 2 microglobulin beta 2m in patients infected with human immunodeficiency virus type 1 hiv 1. Neurology 39(3 Suppl 1): 381
Wilkins, J.; Singer, E.; Mitsuyasu, R.; Syndulko, K.; Setoda, D.; Gaffield, J.; Fahy Chandon, B.; Singer, P.; Tourtellotte, W.W. 1990: Cerebrospinal fluid csf biogenic amines and cortisol are altered by zidovudine azt therapy for the aids dementia complex adc. Neurology 40(4 Suppl 1): 237
Russell, I.J.; Vaeroy, H.; Javors, M.; Nyberg, F. 1990: Cerebrospinal fluid csf biogenic amines in fibrositis fibromyalgia syndrome fs. Arthritis and Rheumatism 33(9 Suppl): S55
Hayes, R.L.; Koslow, M.; Hiesiger, E.M.; Moore, E.; Pierz, D.M.; Ransohoff, J. 1992: Cerebrospinal fluid csf eosinophilia associated with clinical response to il 2 lak cell therapy. Proceedings of the American Association for Cancer Research Annual Meeting 33: 326
Rivera, L.I.; Lin R H.; Gootman, P.M.; Cohen, H.L.; Gootman, N. 1989: Cerebrospinal fluid csf levels of magnesium during iv infusion of magnesium chloride in developing swine. Society for Neuroscience Abstracts 15(2): 1025
Schutzer, S.E.; Coyle, P.K. 1989: Cerebrospinal fluid csf markers in neurologic lyme disease. Clinical Research 37(2): 439A
Eisenach, J.C. 1992: Cerebrospinal fluid csf pharmacodynamics and a possible cholinergic mechanism of epidural clonidine analgesia in humans. Anesthesiology 77(3A): A869
Korn, S.; Barbieri, E.J.; Dehoratius, R.J. 1989: Cerebrospinal fluid csf substance p sp in neuropsychiatric systemic lupus erythematosus np sle. Arthritis and Rheumatism 32(4 Suppl): S114
Cush, J.J.; Lightfoot, E.; Duby, A.D.; Lipsky, P.E. 1989: Cerebrospinal fluid csf t cell clones from patients with active lupus cerebritis. Arthritis and Rheumatism 32(4 Suppl): S120
Lynn, J.; Kissel, J.T.; Rammohan, K.W. 1992: Cerebrospinal fluid csf terminal complement complex in multiple sclerosis. Neurology 42(4 Suppl 3): 248
Chanoine, J.P.; Alex, S.; Stone, S.; Fang, S.L.; Braverman, L.E. 1991: Cerebrospinal fluid csf thyroxine t4 is a significant source of brain t4 in the rat. Hormone Research 35(Suppl 2): 16
Pourcyrous, M.; Parfenova, H.; Bada, H.S.; Korones, S.B.; Leffler, C.W. 1996: Cerebrospinal fluid cyclic AMP during continuous intravenous infusion of dopamine in newborn pigs. Pediatric Research 39(4 Part 2): 239A
Perrella, O.; Carrier, P.B.; Finelli, L.; Perrella, A.; Soscia, E.; La Via, M.F. 1993: Cerebrospinal fluid cytokine profile in multiple sclerosis What correlation?. Journal of Leukocyte Biology 1993(Suppl ): 125
Muller, K.M.I.; Matikainen, E.; Andersson, L.C. 1993: Cerebrospinal fluid cytology in patients with chronic occupational exposure to mixtures of organic solvents. Neurotoxicology (Little Rock) 14(4): 546
Walts, A.E. 1992: Cerebrospinal fluid cytology: selected issues. Diagnostic Cytopathology 8(4): 394-408
Naylor, J.C.; Hulette, C.M.; Steffens, D.C.; Shampine, L.J.; Ervin, J.F.; Payne, V.M.; Massing, M.W.; Kilts, J.D.; Strauss, J.L.; Calhoun, P.S.; Calnaido, R.P.; Blazer, D.G.; Lieberman, J.A.; Madison, R.D.; Marx, C.E. 2008: Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage. Journal of Clinical Endocrinology and Metabolism 93(8): 3173-3178
Roy, A. 1991: Cerebrospinal fluid diazepam binding inhibitor in depressed patients and normal controls. Neuropharmacology 30(12b): 1441-1444
Gomez, D.G.; Manzo, M.V.; Manzo, R.P.; Vullo, T.; Deck, M.; Cahill, P. 1994: Cerebrospinal fluid distribution within the brain. FASEB Journal 8(4-5): A652
Robertson, D.P.; Simpson, R.K. 1996: Cerebrospinal fluid diversion in adults. Tindall, G T, Cooper, P R, Barrow, D L The practice of neurosurgery, vols 1-3 1267-1279
Chodobski, A.; Szmydynger Chodobska, J.; Mckinley, M.J. 1992: Cerebrospinal fluid dynamics in dehydrated sheep. FASEB Journal 6(5): A1836
White, R.P. 1989: Cerebrospinal fluid eicosanoids as an index of cerebrovascular status. Annals of the New York Academy of Sciences 559: 131-145
Chan, A.W.; Macfarlane, I.A.; Masson, E.A.; Venn, R.F.; Morley, J.S.; Bowsher, D.R. 1991: Cerebrospinal fluid enkephalins beta endorphin and somatostatin 14 in painful diabetic neuropathy and sciatica. Journal of Endocrinology 129(Suppl): ABSTRACT 313
Reis Filho, J.B.D.; Iazzeti, A.V.; Kanda, P.A.M.; Pires, L.A. 1989: Cerebrospinal fluid eosinophilia and septic meningitis. Neurobiologia 52(2): 127-132
Peskind, E.R.; Elrod, R.; Dobie, D.J.; Pascualy, M.; Petrie, E.; Jensen, C.; Brodkin, K.; Murray, S.; Veith, R.C.; Raskind, M.A. 1998: Cerebrospinal fluid epinephrine in Alzheimer's disease and normal aging. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 19(6): 465-471
Hall, C.D.; Snyder, C.; Robertson, K.; Messenheimer, J.; Wilkins, J.; Whaley, R.; Silverman, L.; Robertson, W.; Van Der Horst, C. 1990: Cerebrospinal fluid evaluation in hiv positive subjects. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Fb392
Nolli, M.L.; Picinni, P.; Tripepi, A.; Polamarasetti, T.R.; Pizzolato, G.; Pellegrini, A.; Orlando, F.; Dam, M. 1993: Cerebrospinal fluid examination as a possible predictor of neurological outcome in patients with acute liver failure. Transplantation Proceedings 25(3): 2218-2219
Gomes, Helio Rodrigues 1996: Cerebrospinal fluid examination in encephalitis and meningoencephalitis Critical evaluation. Machado, L D R , Livramento, Journal A , Spina-Franca Netto, A , Smith Nobrega, Journal P Neuroinfection 96 Neuroinfeccao 96 : 17-22
Lalonde, R.G.; Briedis, D.J.; Horn, R.; Rene, P.; Robson, H.G. 1989: Cerebrospinal fluid examination in late latent syphilis. Clinical and Investigative Medicine 12(Suppl 4): B59
Alper, C.; Alper, G.; Small, S.L. 1995: Cerebrospinal fluid examination in patients with symptoms of central nervous system dysfunction following organ transplantation. Neurology 45(4 Suppl 4): A256
Jakobson, A.M.; Kreuger, A.; Mortimer, O.; Henningsson, S.; Seidel, H.; Moe, P.J. 1992: Cerebrospinal fluid exchange after intrathecal methotrexate overdose. A report of two cases. Acta Paediatrica 81(4): 359-361
Nigam, M.; Ishiwa, S.; Ichord, R.N.; Johnston, M.V. 1996: Cerebrospinal fluid excitatory amino acid levels in neurologically normal neonates. Pediatric Research 39(4 Part 2): 378A
Annamalai, K.; Naicker, V.L.; Doorsamy, T.; Bhigjee, A.I. 1998: Cerebrospinal fluid expression patterns of lymphocyte subsets in patients with tuberculous meningitis A flow cytometric study. Cytometry (Suppl 9): 107
Perrella, O.; Carrier, P.B.; Perrella, A.; Soscia, E.; Buscaino, G.A.; Finelli, L. 1993: Cerebrospinal fluid ferritin and cytokines in AIDS-dementia complex What correlation?. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 292
Menna Barreto, M.; Bianchini, O.; Jardim, C.; Steinstrasser, L.E.; Bernardi, R. 1997: Cerebrospinal fluid ferritin levels in HTLV-II and HTLV-I infected patients. Journal of the Neurological Sciences 150(Suppl ): S231
Haas, J.; Sailer, M.; Duzel, E.; Tendolkar, I.; Wuerster, U.; Heinze, H.J. 1995: Cerebrospinal fluid filtration in multiple sclerosis in patients as an experimental therapeutic approach. Journal of Neuroimmunology 1995(Suppl 1): 37
Coyle, P.K.; Dattwyler, R.J.; Krupp, L.B.; Belman, A.L.; Benach, J.L.; Luft, B.J. 1993: Cerebrospinal fluid findings in North American Lyme disease. Neurology 43(4 Suppl 2): A218-A219
Pirskanen, R.; Samuelsson, K.; Sonnerborg, A.; Waldenlind, L. 1994: Cerebrospinal fluid findings in asymptomatic HIV patients. Acta Neurologica Scandinavica 89(Suppl 155): 14
D.J.ger A.E.J.; Djojontmodjo, S.; Kuks, J.B.M.; Teelken, A.W. 1990: Cerebrospinal fluid findings in guillain barres syndrome. Clinical Neurology and Neurosurgery 92(2): 187
Towne, A.R.; Boggs, J.G.; Waterhouse, E.J.; Garnett, L.K.; Delorenzo, R.J. 1996: Cerebrospinal fluid findings in status epilepticus. Epilepsia 37(Suppl 5): 212
Rau, H.G.; Schardey, H.M.; Lange, V. 1993: Cerebrospinal fluid fistula as a rare complication of chestwall resection in squamous cell carcinoma of the lung. Chirurg 64(1): 73-75
Macdonald, R.L.; Cusimano, M.D.; Deck, J.H.; Gullane, P.J.; Dolan, E.J. 1990: Cerebrospinal fluid fistula secondary to ecchordosis physaliphora. Neurosurgery 26(3): 515-518; Discussion: 518-519
Lampreave, J.L.; Dominguez, P.; Paz Madariaga, M.; Almoguera, I.; Bittini, A.L. 1997: Cerebrospinal fluid fistula to the maxillary bone demonstrated by In-111 DTPA cisternography. Clinical Nuclear Medicine 22(1): 57-58
Marshall, L.F. 1996: Cerebrospinal fluid fistulae. Tindall, G T, Cooper, P R, Barrow, D L The practice of neurosurgery, vols 1-3 1535-1539
Melada, A.; Ivekovic, V.; Scap, M. 1995: Cerebrospinal fluid fistulas caused by missile head injuries. Journal of Neurotrauma 12(3): 437
Hao, R.; NorgrenRobert, B.Jr.; Pfeiffer, R.F. 1994: Cerebrospinal fluid from individuals with Parkinsons disease inhibits dopaminergic neuron growth and function in vitro. Neurology 44(4 Suppl 2): A154
Xiao, B.G.; Zhang, G.X.; Ma, C.G.; Link, H. 1995: Cerebrospinal fluid from multiple sclerosis patients promotes neuronal and oligo-dendrocyte damage by delayed production of nitric oxide in vitro. Journal of Neuroimmunology 1995(Suppl 1): 55
Li, V.; Watanabe, H.; Yu, C.; Folkman, J. 1992: Cerebrospinal fluid from pediatric brain tumor patients contains a mitogen for capillary endothelial cells. Molecular Biology of the Cell 3(Suppl ): 235A
Izumi, T.; Koizumi, H.; Fukuyama, Y. 1989: Cerebrospinal fluid gangliosides in patients with west syndrome. Epilepsia 30(5): 637
Sy, C-Len.; Tsai, H-Chin.; Wann, S-Ren.; Lee, S.Shin-Jung.; Liu, Y-Ching.; Chen, Y-Shen. 2008: Cerebrospinal fluid hepatocyte growth factor level in meningitis. Journal of Microbiology Immunology and Infection 41(4): 301-306
Blom, H.J.; Wevers, R.A.; Verrips, A.; TePoele-Pothoff, M.T.; Trijbels, J.M. 1993: Cerebrospinal fluid homocysteine and the cobalamin status of the brain. Journal of Inherited Metabolic Disease 16(3): 517-519
Lawrence, S.K.; Sandler, M.P.; Partain, C.L.; James, A.E., J. 1996: Cerebrospinal fluid imaging. Sandler, M P, Patton, J A, Coleman, R E, Gottschalk, A, Wackers, F J T,, Hoffer, P B Diagnostic nuclear medicine, Third edition, Vols 1 and 2 1163-1176
Kranz, B.R.; Thierfelder, S.; Gerl, A.; Wilmanns, W. 1992: Cerebrospinal fluid immunocytology in primary central nervous system lymphoma. Lancet 340(8821): 727
Gupta, V.; Gupta, R.K.; Agarwal, A.; Tripathi, V.N.; Mathur, G.P. 1989: Cerebrospinal fluid immunoglobulins in meningitis. Indian Pediatrics 26(12): 1243-1245
Coyle, P.K.; Schutzer, S.E.; Belman, A.L.; Krupp, L.B.; Dheng, Z. 1992: Cerebrospinal fluid immunologic parameters in neurologic Lyme disease. Schutzer, S E Current Communications in Cell and Molecular Biology; Lyme disease: Molecular and immunologic approaches: 31-43
Greenlee, J.E.; Carroll, K.C. 1997: Cerebrospinal fluid in CNS infections. Scheld, W M, Whitley, R J, Durack, D T Infections of the central nervous system, Second editon: 899-922
Greenlee, J.E. 1991: Cerebrospinal fluid in central nervous system infections. Scheld, W M , R J Whitley And D T Durack (Ed ) Infections Of The Central Nervous System Xix+937p Raven Press: New York, New York, Usa Illus Maps 861-886
Sansaricq, C.; Smith, L.; Faruki, M.; Snyderman, S.E. 1989: Cerebrospinal fluid in maple syrup urine disease msud. Pediatric Research 25(4 Part 2): 202A
Mcmillan, S.A.; Mcdonnell, G.V.; Douglas, J.P.; Hawkins, S.A. 1998: Cerebrospinal fluid indices of inflammatory markers across the clinical spectrum of multiple sclerosis. Journal of Neuroimmunology 90(1): 76
Collier, A.C.; Marra, C.; Coombs, R.W.; Zhong, L.; Stone, J.; Nguyen, B.Y. 1997: Cerebrospinal fluid indinavir and HIV RNA levels in patients on chronic indinavir therapy. Clinical Infectious Diseases 25(2): 359
Kressebuch, H.; Schaad, U.B.; Hirt, A.; Bianchetti, M.G. 1992: Cerebrospinal fluid inflammation induced by intravenous immunoglobulins. Pediatric Infectious Disease Journal 11(10): 894-895
Rubertone, J.A.; Gaffin, N.; Emrich, J.; Brady, L.W. 1993: Cerebrospinal fluid injection of thallium-201 for imaging intraventricular dissemination of brain tumors. Society for Neuroscience Abstracts 19(1-3): 1897
Sheremata, W.A.; Mcfarlin, D.E. 1990: Cerebrospinal fluid interferon g is increased in tropical spastic paraparesis. Society for Neuroscience Abstracts 16(1): 614
Mastroianni, C.M.; Paoletti, F.; Rivosecchi, R.M.; Lancella, L.; Ticca, F.; Vullo, V.; Delia, S. 1994: Cerebrospinal fluid interleukin 8 in children with purulent bacterial and tuberculous meningitis. Pediatric Infectious Disease Journal 13(11): 1008-1010
Tsai, M.L.; Chen, W.C.; Wang, Y.C.; Hung, K.L. 1996: Cerebrospinal fluid interleukin-6, interleukin-8, and tumor necrosis factor-alpha in children with central nervous system infections. Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 37(1): 16-21
Laverda A.M.; Gallo P.; De Rossi A.; Rampazzo M.; Chieco Bianchi L.; Tavolato B. 1990: Cerebrospinal fluid investigations in hiv 1 infected children. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sb204
Vaeroy, H.; Nyberg, F.; Terenius, L. 1990: Cerebrospinal fluid investigations in patients with fibromyalgia fibrositis syndrome met arg 6 phe 7 dyn a1 17 substance p and beta endorphin. Pain (Suppl 5): S55
Yamaji, I.; Shimamoto, K.; IImura, O.; Margolius, H.S.; Privitera, P.J. 1990: Cerebrospinal fluid kallikrein in hypertensive rat. Japanese Circulation Journal 54(7): 766
Khan, I.M.; Yamaji, I.; Strickland, J.A.; Margolius, H.S.; Privitera, P.J. 1989: Cerebrospinal fluid kallikrein in hypertensive rat models. Circulation 80(4 Suppl 2): II102
Teddy, P.J.; Glynn, C.J.; Jamous, M.A. 1990: Cerebrospinal fluid kinetics of epidural clonidine. Pain (Suppl 5): S105
Donald, P.R.; Schoeman, J.F.; Van Zyl, L. 1989: Cerebrospinal fluid lactate and raised intracranial pressure in tuberculous meningitis. Journal of Tropical Pediatrics 35(5): 263-264
Gunnoe, E.; Berkowitz, I.D.; Newton, C.; Wilson, D.; Brusilow, S.; Traystman, R.J. 1996: Cerebrospinal fluid lactic acidosis does not contribute to cerebral hyperemia in Haemophilus influenzae type B meningitis in rabbits. FASEB Journal 10(3): A588
Buchwald, C.; Tos, M.; Thomsen, J. 1991: Cerebrospinal fluid leak from nontumor ear after acoustic neuroma surgery: diagnostic and therapeutic problems. American Journal of Otology 12(5): 384-387
Magliulo, G.; Sepe, C.; Varacalli, S.; Fusconi, M. 1998: Cerebrospinal fluid leak management following cerebellopontine angle surgery. Journal of Otolaryngology 27(5): 258-262
Haridas, R.P. 1997: Cerebrospinal fluid leak with combined spinal-epidural analgesia. Anesthesiology 87(3 Suppl): A785
Graamans, Kees; De Groot, John A.M.; Tulleken, Cornelis A.F. 1994: Cerebrospinal fluid leakage via the eustachian tube after translabyrinthine surgery. Samii, M Skull base surgery: Anatomy, diagnosis and treatment 1236-1238
Bryce, G.E.; Nedzelski, J.M.; Rowed, D.W.; Rappaport, J.M. 1991: Cerebrospinal fluid leaks and meningitis in acoustic neuroma surgery. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 104(1): 81-87
Prasad, C.; Hilton, C.W.; Lohr, J.B.; Robertson, H.J.F. 1990: Cerebrospinal fluid level of cyclo his pro a peptide endogenous to hypothalamus is elevated in schizophrenics. Clinical Research 38(4): 993A
Camp, V.M.; Watts, R.L.; Risby, E.; Risch, C.; Faraj, B.A. 1990: Cerebrospinal fluid level of salsolinol sulfate in controls parkinsons disease and schizophrenia. Alcoholism Clinical and Experimental Research 14(2): 275
Mosqueda Garcia, R.; Sugiura, M.; Beck, C.; Inagami, T.; Robertson, R.M. 1990: Cerebrospinal fluid levels and central cardiovascular effects of microinjection of endothelin in the brainstem of anesthetized rats. Circulation 82(4 Suppl 3): III453
Growdon, J.; Deng, A.; Thomsen, T.M.; Mann, U.; Buhmann, J.; Sturenburg, H.J.; Eggers, C.; Langer, U.; Velden, J.; Von Der Kammer, H.; Wiegmann, H.; Kunze, S.; Naber, D.; Rebeck, B.; Schoenfeld, D.; Hock, C.; Nitsch, R. 1998: Cerebrospinal fluid levels of a novel presenilin loop fragment are increased in Alzheimers disease. Neurology 50(4 Suppl 4): A313-A314
Growdon, J.H.; Rebeck, G.W.; Deng, M.; Richardson, U.I.; Tennis, M.; Schnek, D.B.; Lieberburg, C.V.V. Pelfreyan; Wurtman, R.J.; Hyman, B.T.; Nitsch, R.M. 1994: Cerebrospinal fluid levels of amyloid beta-protein are independent of apolipoprotein E genotype and are inversely correlated with severity of dementia in Alzheimers disease. Society for Neuroscience Abstracts 20(1-2): 1056
Farlow, M.R.; Ghetti, B.; Dlouhy, S.; Giaccone, G.; Bugiani, O.; Tagliavini, F.; Wagner, S. 1993: Cerebrospinal fluid levels of amyloid beta-protein precursor are low in an Indiana kindred with Gerstmann-Straussler-Scheinker disease. Neurology 43(4 Suppl 2): A193
Golombowski, S.; Hock, C.; Nitsch, R.M.; Mueller Spahn, F. 1997: Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimers disease and major depression. Pharmacopsychiatry 30(5): 171
Pelton, G.H.; Mcdougle, C.J.; Carpenter, L.; Anderson, G.M.; Gudin, J.A.; Price, L.H.; Malison, R.T.; Kirwin, P.; Heninger, G.R. 1997: Cerebrospinal fluid levels of interleukin-1 and interleukin-6 increase after intravenous lipopolysaccharide in healthy humans. Society for Neuroscience Abstracts 23(1-2): 992
Kusuhara, T.; Ayabe, M.; Hino, H.; Shoji, H.; Yamada, S. 1996: Cerebrospinal fluid levels of monoamines in patients with Japanese encephalitis. European Neurology 36(4): 236-237
Hintzen, R.Q.; Paty, D.; Oger, J.J.F. 1998: Cerebrospinal fluid levels of soluble CD27 correlate with disease activity in multiple sclerosis and with disease state in HTLV-1 associated HAM/TSP. Journal of Neuroimmunology 90(1): 66
Bradley, Laurence A.; Alarcon, Graciela S.; Sotolongo, Adriana; Weigent, Douglas A.; Alberts, Kristin R.; Blalok, Edwin; Kersh, Brian C.; Domino, Maria L.; De Waal, Derek 1998: Cerebrospinal fluid levels of substance P are abnormal in patients with fibromyalgia regardless of traumatic or insidious pain onset. Arthritis and Rheumatism 41(9 Suppl): S256
Soininen, H.; Tapiola, T.A.; Alafuzoff, I.I.; Lehtovirta, M.; Ramberg, J.; Helisalmi, S.; Linnaranta, K.; Riekkinen, P.J.Sr 1997: Cerebrospinal fluid levels of tau in dementia Relation to apolipoprotein E genotype in early Alzheimers disease and correlation with neurofibrillary tangles. Neurology 48(3 Suppl 2): A379
Zemlan, F.; Campbell, T.; Dean, G. 1997: Cerebrospinal fluid levels of tau protein in Alzheimers disease and CNS injury. Society for Neuroscience Abstracts 23(1-2): 2220
Tobias, J.D. 1991: Cerebrospinal fluid losses through ventricular catheters leading to hyponatremia in two children. Southern Medical Journal 84(2): 279-280
Sepiashvili, R.; Malashkhia, Y. 1991: Cerebrospinal fluid lymphocytes new function is a neurotransmitters synthesis. Journal of Neuroimmunology (Suppl 1): 208
Massaro, A.R.; Scivoletto, G.; Tonali, P. 1990: Cerebrospinal fluid markers in neurological disorders. Italian Journal of Neurological Sciences 11(6): 537-547
Coyle, P.K.; Krupp, L.B.; Deng, Z.; Belman, A.L.; Dattwyler, R.J.; Luft, B.J. 1995: Cerebrospinal fluid markers of CNS invasion in early Lyme disease. Neurology 45(4 Suppl 4): A438-A439
Van Gool, W.A.; Bolhuis, P.A. 1991: Cerebrospinal fluid markers of Alzheimer's disease. Journal of the American Geriatrics Society 39(10): 1025-1039
Fontenot, M.B.; Kaplan, J.R.; Phillips Conroy, J.; Jolly, C.J.; Mann, J.J. 1997: Cerebrospinal fluid monoamine metabolite concentrations in adult male baboons Field studies in the Awash River Valley, Ethiopia. American Journal of Physical Anthropology 1997(Suppl 24): 112
Heilig, M.; Månsson, J.E.; Blennow, K. 1996: Cerebrospinal fluid monoamine metabolites and atmospheric pressure. Biological Psychiatry 39(4): 299-301
Mastroianni, C.M.; Liuzzi, G.M.; Vullo, V.; Delia, S.; Riccio, P. 1992: Cerebrospinal fluid myelin basic protein in AIDS dementia complex: relationship to disease progression and zidovudine treatment. Aids 6(10): 1214-1215
Lucey, D.R.; Mcguire, S.A.; Abbadessa, S.; Hall, K.; Woolford, B.; Valtier, S.; Butzin, C.A.; Melcher, G.P.; Hendrix, C.W. 1994: Cerebrospinal fluid neopterin levels in 159 neurologically asymptomatic persons infected with the human immunodeficiency virus Relationship to immune status. Viral Immunology 6(4): 267-272
Speciale, S.G.; Chong, J.; Weiner, M.; Hom, J.; Bonte, F.; Risser, R.; Tintner, R. 1993: Cerebrospinal fluid neural thread protein in dementia Relationship to clinical measures. Society for Neuroscience Abstracts 19(1-3): 194
Bach, F.W.; Langemark, M.; Ekman, R.; Schifter, S.; Olesen, J. 1992: Cerebrospinal fluid neuropeptides in patients with chronic headache. Anesthesiology 77(3A): A175
Maertens, P.; Butler, I.J. 1989: Cerebrospinal fluid neurotransmitters in menkes disease. Neurology 39(3 Suppl 1): 157-158
Takaragi, S.; Horiuchi, T.; Miyahira, H.; Hamano, I.; Endo, A.; Yoda, T.; Egawa, B.; Yamamoto, H.; Meguro, T.; Yamada, K. 1989: Cerebrospinal fluid neurotransmitters of the newborn with neonatal asphyxia. Acta Paediatrica Japonica: Overseas Edition 31(6): 745-747
Duran, M.; Baumgartner, E.R.; Suormala, T.M.; Bruinvis, L.; Dorland, L.; Smeitink, J.A.; Poll-The, B.T. 1993: Cerebrospinal fluid organic acids in biotinidase deficiency. Journal of Inherited Metabolic Disease 16(3): 513-516
Jones, N.S. 1991: Cerebrospinal fluid otorrhea at myringotomy. a meningocele through a defect in the tegmen. International Journal of Pediatric Otorhinolaryngology 21(1): 79-83
Ristuccia, A.M.; Le Frock, J.L. 1992: Cerebrospinal fluid penetration of antimicrobials. Antibiotics and ChemoTherapy 45: 118-152
Nix, D.E.; Wilton, J.H.; Mitchell, P.; Schentag, J.J.; Valasquez, N.; Budny, J.L.; Lassman, H.B. 1991: Cerebrospinal fluid penetration of cefpirome in non inflamed meninges. Pharmacotherapy 11(3): 268
Ravid, R.; Van Zwieten, E.J.; Swaab, D.F.; Kamphorst, W. 1992: Cerebrospinal fluid ph is not influenced by post mortem interval in alzheimers and controls. Neurobiology of Aging 13(Suppl 1): S32-S33
Reid, J.M.; Berg, S.; Ames, M.M.; Poplack, F.M.; Feig, S.; Kuffel, M.J.; Hammond, D. 1993: Cerebrospinal fluid pharmacokinetics of idarubicin and idarubicinol. Proceedings of the American Association for Cancer Research Annual Meeting 34: 394
Simic, G.; Boban, M.; Hof, P., R. 2008: Cerebrospinal fluid phosphorylated tau proteins as predictors of Alzheimers disease in subjects with mild cognitive impairment. Periodicum Biologorum 110(1): 27-30
Lyons, M.K.; Meyer, F.B. 1990: Cerebrospinal fluid physiology and the management of increased intracranial pressure. Mayo Clinic Proceedings 65(5): 684-707
Hansen, A.R.; Whitclaw, A.G.L.; Lapp, C.N.; Brugnara, C. 1996: Cerebrospinal fluid plasminogen activator inhibitor-I a prognostic factor in posthemorrhagic hydrocephalus. Pediatric Research 39(4 Part 2): 214A
Malley, R.; Inkelis, S.H.; Coelho, P.; Huskins, W.C.; Kuppermann, N. 1998: Cerebrospinal fluid pleocytosis and prognosis in invasive meningococcal disease in children. Pediatric Infectious Disease Journal 17(10): 855-859
Severs, W.B.; Searles, R.V. 1993: Cerebrospinal fluid pressure after head down tilt in anesthetized rats. FASEB Journal 9(3): A26
Schoenwald, P.; Gottlieb, A.; Lewis, B.; O'hara P. 1992: Cerebrospinal fluid pressure csfp during aortic cross clamp xc as a predictor of neurologic outcome during thoracoabdominal aneurysm repair. Anesthesiology 77(3A): A71
Felton, W.L.IIi; Marmarou, A.; Bandoh, K. 1991: Cerebrospinal fluid pressure dynamics in pseudotumor cerebri. Neurology 41(3 Suppl 1): 348
Berdahl, J.P.; Allingham, R.Rand.; Johnson, D.H. 2008: Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology 115(5): 763-768
Allen, B.T.; Doblas, M.; Owen, J.; Anderson, C.B.; Davis, C.; Sicard, G.A.; Kai, Y. 1991: Cerebrospinal fluid pressure somatosensory and motor evoked potentials in spinal cord ischemia after lumbar artery ligation. Surgical Forum 42: 262-265
Ortega, J.; Lopez, F.; Sanchez Valverde, M.A.; Agut, A.; Laredo, F.G. 1991: Cerebrospinal fluid pressures in rat after permanent implantation of a catheter in the lateral ventricle. Anales de Veterinaria de Murcia 6-7: 57-63, 1990
Dengler, L.D.; Capparelli, E.V.; Bastian, J.; Bradley, D.J.; Glode, M.P.; Santa, S.; Newburger, J.; Baker, A.L.; Burns, J.C. 1997: Cerebrospinal fluid profile in patients with acute Kawasaki Disease. Journal of Investigative Medicine 45(1): 89A
Friedman, H.S.; Kurtzberg, J.; Schold, S.C.; Oakes, W.J. 1989: Cerebrospinal fluid protein elevation secondary to a subdural fluid collection in a child receiving multiple lumbar punctures. Journal of Pediatrics 115(3): 439-441
Nespolo, A.; Aguzzi, F.; Cerrato, D.; Salmaggi, A.; Tajoli Malesani, L.; Croci, D.; Del Campo, G.B.; Fenili, D.; Graziani, M.S. 1990: Cerebrospinal fluid proteins and electrophoresis of cerebrospinal fluid proteins official recommendation of the sibioc 05 commission. Giornale Italiano di Chimica Clinica 15(1): 73-78
Pirttila, T.; Mattila, K.; Frey, H. 1991: Cerebrospinal fluid proteins in alzheimer type and multi infarct dementia 2 d electrophoretic analysis. Journal of Neurochemistry 57(Suppl): S113
Siddiqui, A.A.; Ali, T.Z.; Ali, N.M.; Khurshid, M.; Waqar, M.A. 1989: Cerebrospinal fluid proteins in meningitis. Biochemical Society Transactions 17(2): 415-417
Wang, F.; Miller, J.H. 1989: Cerebrospinal fluid pseudocyst presenting as a hepatic mass: a complication of ventriculoperitoneal shunt. Pediatric Radiology 19(5): 326-327
Parnetti, L.; Gaiti, A.; Cadini, D.; Mastriforti, R.; Chionne, F.; Gallai, V. 1998: Cerebrospinal fluid pyruvate levels in Alzheimers disease and vascular dementia. Neurology 50(4 Suppl 4): A410
Heyes, M.P.; Brew, B.J.; Price, R.W.; Markey, S.P. 1990: Cerebrospinal fluid quinolinic acid and kynurenic acid in hiv 1 infection. Guidotti, A (Ed ) Fidia Research Foundation Symposium Series, Vol 4 Neurotoxicity Of Excitatory Amino Acids; Symposium, Scottsdale, Arizona, Usa, October 26-28, 1989 Xix+340p Raven Press: New York, New York, Usa Illus 217-222
Bell, W.O. 1989: Cerebrospinal fluid reabsorption. Marlin, A E (Ed ) Concepts in Pediatric Neurosurgery, Vol 10; Annual Meeting Of The American Society For Pediatric Neurosurgery, Vii+262p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 214-234
Visot, A.; Cophignon, J.; Derome, P.J. 1979: Cerebrospinal fluid rhinorrhea. Annales de Chirurgie 33(5): 319-327
Zlab, M.K.; Moore, G.F.; Daly, D.T.; Yonkers, A.J. 1992: Cerebrospinal fluid rhinorrhea: a review of the literature. Ear Nose and Throat Journal 71(7): 314-317
Coculescu, R.; Finer, N. 1994: Cerebrospinal fluid rhinorrhoea and meningitis after bromocriptine therapy for an invasive macroprolactinoma. Journal of Endocrinology 140(Suppl ): ABSTRACT P57
Magram, G. 1995: Cerebrospinal fluid shunt. Official Gazette of the United States Patent and Trademark Office Patents 1173(2): 1035
Kirsch, W.M.; Zhu, Y.H. 1995: Cerebrospinal fluid shunt capable of minimal invasive revision. Official Gazette of the United States Patent and Trademark Office Patents 1170(5): 2983
Bryant, K.; Reisner, A.; Marshall, G.S. 1997: Cerebrospinal fluid shunt infection caused by Yersinia enterocolitica. Pediatric Infectious Disease Journal 16(11): 1092-1093
Mturi, N.; Keir, G.; Maclennan, C.A.; Ross, A.; Willis, A.C.; Elford, B.C.; Berkley, J.A.; Newton, C.R.J.C. 2008: Cerebrospinal Fluid Studies in Kenyan Children with Severe Falciparum Malaria. Open Tropical Medicine Journal 1: 56-62
Musselman, D.L.; Haden, C.; Caudle, J.; Kalin, N.H.; Lewine, R.R.; Risch, S.C. 1994: Cerebrospinal fluid study of cannabinoid users and normal control subjects. Psychiatry Research 52(1): 103-105
Russell, I.J.; Fletcher, E.M.; Vipraio, G.A.; Lopez, Y.; Orr, M.A. 1998: Cerebrospinal fluid substance P in fibromyalgia Changes in CSF SP over time parallel changes in clinical activity. Arthritis and Rheumatism 41(9 Suppl): S256
Russell, I.J.; Orr, M.D.; Vipraio, G.A.; Alboukrek, D.; Michalek, J.E.; Mackillip, F.; Lopez, Y.M.; Littman, B.H. 1993: Cerebrospinal fluid substance P is elevated in fibromyalgia syndrome. Arthritis and Rheumatism 36(9 Suppl): S223
Arai, H.; Terajima, M.; Nakagawa, T.; Kosaka, Y.; Matsui, T.; Higuchi, S.; Muramatsu, T.; Matsushita, S.; Iwatsubo, T.; Kosaka, T.; Miura, M.; Machida, T.; Clark, C.; Lee, V.M.Y.; Trojanowski, J.Q.; Sasaki, H. 1996: Cerebrospinal fluid tau and A-beta protein levels as biological markers for clinical diagnosis of Alzheimers disease. Society for Neuroscience Abstracts 22(1-3): 1422
Arai, H.; Clark, C.M.; Ewbank, D.C.; Takase, S.; Higuchi, S.; Miura, M.; Seki, H.; Higuchi, M.; Matsui, T.; Lee, V.M.; Trojanowski, J.Q.; Sasaki, H. 1998: Cerebrospinal fluid tau protein as a potential diagnostic marker in Alzheimer's disease. Neurobiology of Aging 19(2): 125-126
Ellis, R.J.; Seubert, P.; Motter, R.; Galasko, D.; Heyes, M.; Atkinson, J.H.; Grant, I. 1997: Cerebrospinal fluid tau protein is not elevated in HIV neurologic disease. Society for Neuroscience Abstracts 23(1-2): 836
Suzuki, H.; Kinoshita, N.; Imanaka-Yoshida, K.; Yoshida, T.; Taki, W. 2008: Cerebrospinal fluid tenascin-C increases preceding the development of chronic shunt-dependent hydrocephalus after subarachnoid hemorrhage. Stroke 39(5): 1610-1612
Henneberg, A.E.; Link, D.; Bittmann, H.; Wollinsky, K.H. 1994: Cerebrospinal fluid won by lumbar puncture A useful tool for immunological studies in multiple sclerosis patients?. Immunobiology 2-3: 97
Tapiola, T.; Pirttila, T.; Kivimaki, T.; Mehta, P.D.; Riekkinen, P.Sr; Soininen, H. 1998: Cerebrospinal fluid, but not serum Abeta42 concentration is decreased in Alzheimers disease. Society for Neuroscience Abstracts 24(1-2): 723
Hoffman, C.E.; Souweidane, M.M. 2008: Cerebrospinal fluid-related complications with autologous duraplasty and arachnoid sparing in type i Chiari malformation. Neurosurgery 62(3 Suppl 1: 156-160; Discussion: 160-161
Binoux, M.; Roghani, M.; Hossenlopp, P.; Whitechurch, O. 1991: Cerebrospinal IGF binding proteins: isolation and characterization. Advances in Experimental Medicine and Biology 293: 161-170
Bacchi, O.; Stefanucci, S.; Brustenghi, P.L.; Pagliacci, A.; Bellanti, G.M. 1992: Cerebrotendinous xanthomatosis. Case report. Italian Journal of Neurological Sciences 13(6): 511-515
Dotti, M.T.; Mondillo, S.; Plewnia, K.; Agricola, E.; Federico, A. 1998: Cerebrotendinous xanthomatosis: evidence of lipomatous hypertrophy of the atrial septum. Journal of Neurology 245(11): 723-726
Verrips, A.; Steenbergen, G.C.H.; Van Den Heuvel, L.P.W.J.; Keyser, A.; Gabreels, F.J.M.; Wevers, R.A. 1997: Cerebrotendinous xanthomatosis Mutations in the sterol 27-hydroxylase gene in the Dutch population. Journal of Inherited Metabolic Disease 20(Suppl 1): 101
Pilo de la Fuente, B.; Ruiz, I.; Lopez de Munain, A.; Jimenez-Escrig, A. 2008: Cerebrotendinous xanthomatosis: neuropathological findings. Journal of Neurology 255(6): 839-842
Fiorelli, M.; Di Piero, V.; Bastianello, S.; Bozzao, L.; Federico, A. 1990: Cerebrotendinous xanthomatosis: clinical and MRI study (a case report). Journal of Neurology Neurosurgery and Psychiatry 53(1): 76-78
Chang, W.N.; Kuriyama, M.; Lui, C.C.; Jeng, S.F.; Chen, W.J.; Chee, E.C. 1992: Cerebrotendinous xanthomatosis in three siblings from a Taiwanese family. Journal of the Formosan Medical Association 91(12): 1190-1194
Weyland, A.; Van Der Velde, J.; Gruene, F.; Kazmaier, S.; Sonntag, H. 1996: Cerebrovascular CO-2 reactivity during cardiopulmonary bypass Measurements of cerebral blood flow versus middle cerebral artery flow velocity. Anesthesiology 85(3A): A106
Larsen, F.S.; Hansen, B.A.; Paulson, O.B.; Knudsen, G.M. 1995: Cerebrovascular CO-2 reactivity in patients with fulminant hepatic failure. Hepatology 22(4 Part 2): 444A
Larsen, F.S.; Hansen, B.A.; Paulson, O.B.; Knudson, G.M. 1995: Cerebrovascular CO-2 reactivity is decreased in rat with thioacetamide-induced liver failure. Hepatology 22(4 Part 2): 250A
Baccoli, M.J.; Haller, J.S.; Davenport, C.J. 1995: Cerebrovascular Disease in Pediatric Acquired Immune Deficiency Syndrome. Neurology 45(4 Suppl 4): A348
Johnson, M.H. 1995: Cerebrovascular MRI. Faerber, E N Clinics in Developmental Medicine; CNS magnetic resonance imaging in infants and children 146-163
Rizzo, J.F.; Lessell, S. 1994: Cerebrovascular abnormalities in neurofibromatosis type 1. Neurology 44(6): 1000-1002
Wiznitzer, M.; Smith, A.; Berman, B. 1992: Cerebrovascular abnormalities in sickle cell disease parenchymal and vascular magnetic resonance assessment. Neurology 42(4 Suppl 3): 460
Tenne, D.; Behar, S. 1992: Cerebrovascular accident among 4809 survivors from acute myocardial infarction. Circulation 86(4 Suppl 1): I148
Maaravi, Y.; Raz, E.; Gilon, D.; Rubinow, A. 1989: Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus. Annals of the Rheumatic Diseases 48(10): 853-855
Rotstein, Z.; Achiron, A.; Eldar, M.; Noy, S.; Barak, Y. 1998: Cerebrovascular accident as a predictor of mortality following acute myocardial infarction. European Journal of Neurology 5(Suppl 1): S22
Rappa, P.J.; Porter, L. 1991: Cerebrovascular accident as the initial presentation of human immunodeficiency virus infection. Archives of Physical Medicine and Rehabilitation 72(10): 840
Gandia, D.; Spielmann, M.; Kac, J.; Elias, D.; Girinsky, T.; Guillot, T.; Rougier, P. 1992: Cerebrovascular accident associated with chemotherapy for oesophageal carcinoma. European Journal of Cancer 28(1): 245
Whiting, J.H.; Datz, F.L.; Gabor, F.V.; Jones, S.R.; Morton, K.A. 1993: Cerebrovascular accident associated with dipyridamole thallium-201 myocardial imaging: case report. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 34(1): 128-130
Ahmad, K. 1998: Cerebrovascular accident in Damascus Hospital. European Journal of Neurology 5(Suppl 1): S40
D.P.essis, A.J.; Chang, A.C.; Wernovsky, G.; Wessel, D.L.; Lock, J.E.; Mayer, J.E. 1993: Cerebrovascular accidents following the Fontan procedure. Circulation 88(4 Part 2): I290
Tsuruta, Y.; Tsukune, K.; Yanai, M. 1993: Cerebrovascular accidents in dialysis patients Estimation according to magnetic resonance imaging. Nephrology Dialysis Transplantation 8(9): 1013-1014
Smeda, J.; King, S. 1996: Cerebrovascular alterations associated with hemorrhagic stroke. FASEB Journal 10(3): A29
Ando, K. 1994: Cerebrovascular aminergic and acetylcholinesterase-positive innervation in the newt, with special attention to the choroid plexus. Zoological Science 11(Suppl ): 29
Thormodsson, F.R.; Olafsson, I.H.; Hrafnsdottir, M.G.; Blondal, H. 1996: Cerebrovascular amyloid in hereditary cystatin C amyloidosis and vascular smooth muscle cells. Society for Neuroscience Abstracts 22(1-3): 2132
Chong, K.Y.; Gelb, A.W. 1994: Cerebrovascular and cerebral metabolic effects of commonly used anaesthetics. Annals of the Academy of Medicine Singapore 23(6 Suppl): 145-149
Nikolov, R.K.; Semkova, I.S. 1992: Cerebrovascular and cns effects of endothelins target for pharmacological modification?. Drugs of Today 28(5): 303-310
Vasthare, U.S.; Mcallister, J.P.; Hale, P.M.; Rosenwasser, R.H.; Way, J.S. 1991: Cerebrovascular and evoked potential effects of neonatal hydrocephalus. Society for Neuroscience Abstracts 17(1-2): 1263
Low, P.A.; Novak, V.; Fujimura, J.; Novak, P. 1997: Cerebrovascular and mesenteric vasoregulation in autonomic failure. Journal of the Autonomic Nervous System 65(2-3): 70
Wolff, J. 1990: Cerebrovascular and metabolic effects of midazolam and flumazenil. Acta Anaesthesiologica Scandinavica. Supplementum 92: 75-77
Lowe, J. 1995: Cerebrovascular and neurodegenerative diseases An approach for general histopathologists. Kirkham, N , Hall, P A Progress in Pathology, Vol 1 151-177
Ross, J.S. 1993: Cerebrovascular applications of magnetic resonance angiography. Annals of the Academy of Medicine Singapore 22(5): 749-756
Parfenov, V.A.; Gorbacheva, F.E.; Gerasimova, O.N. 1992: Cerebrovascular aspects of antihypertensive therapy. Rossiiskii Meditsinskii Zhurnal: Organ Ministerstva Zdravookhraneniia Rsfsr 1992(5-12): 38-40
Barry, D.I. 1989: Cerebrovascular aspects of antihypertensive treatment. American Journal of Cardiology 63(6): 14c-18c
Slater, A.J.; Berkowitz, I.D.; Wilson, D.A.; Traystman, R.J. 1993: Cerebrovascular autoregulation in Haemophilus influenzae type B meningitis in rabbits The role of leukocytes. FASEB Journal 7(3-4): A531
Schwenk, K.L.; Greenless, G.N.; Sherman, R.G.; Crutcher, K.A.; Isaacson, L.G. 1995: Cerebrovascular axons on the aged rat respond to intracerebroventricular infusion of nerve growth factor. Society for Neuroscience Abstracts 21(1-3): 1541
Diringer, M.N.; Kirsch, J.R.; Hanley, D.F.; Traystman, R.J. 1992: Cerebrovascular carbon dioxide reactivity following subarachnoid hemorrhage in cats. FASEB Journal 6(4): A1262
Hashimoto, T.; Nakamura, N.; Hasegawa, Y.; Nakazawa, K. 1992: Cerebrovascular carbon dioxide reactivity using transcranial doppler. Oka, M , Et Al (Ed ) International Congress Series, No 979 Recent Advances in Neurosonology; Fourth Meeting Of The Neurosonology Research Group Of The World Federation Of Neurology, Hiroshima, Japan, June 6-8, 1991 Xix+556p Elsevier Science Publishers B V : Amsterdam, Netherlands; New York, New York, Usa Illus 265-271
Batjer, H.Hunt 1997: Cerebrovascular care in the next decade Cost, prudence, progress, and rationing. Batjer, H H Cerebrovascular disease : 1191-1197
Caplan, L.R.; Estol, C.; Pessin, M.S. 1992: Cerebrovascular case studies. Neurology 42(4 Suppl 3): 127
Alvarez, X.A.; Fernandez Novoa, L.; Caamano, J.; Corzo, L.; Zas, R.; Beyer, K.; Lao, J.I.; Cacabelos, R. 1997: Cerebrovascular changes associated with interleukin-1beta and histamine levels in Alzheimers disease. de la Torre, J C , Hachinski, V Annals of the New York Academy of Sciences; Cerebrovascular pathology in Alzheimer's disease 375-378
Graziani, L.J.; Gringlas, M.; Baumgart, S. 1997: Cerebrovascular complications and neurodevelopmental sequelae of neonatal ECMO. Clinics in Perinatology 24(3): 655-675
Vedanarayanan, V.V.; Longee, D.C.; Dunsmore, K.P.; Delong, G.R.; Kandt, R.S. 1990: Cerebrovascular complications in children with acute lymphoblastic leukemia all treated with intravenous iv and intrathecal it methotrexate mtx. Neurology 40(4 Suppl 1): 360
Snygg-Martin, U.; Gustafsson, L.; Rosengren, L.; Alsiö, A.; Ackerholm, P.; Andersson, R.; Olaison, L. 2008: Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 47(1): 23-30
Murthy, K.N.; Hubert, G.; Hess, J. 1992: Cerebrovascular complications in percutaneous transluminal coronary angioplasty ptca. Neurology 42(4 Suppl 3): 451
Johns, D.R. 1991: Cerebrovascular complications of inflammatory bowel disease. American Journal of Gastroenterology 86(3): 367-370
Gebel, J.M.; Sila, C.A.; Gray, B. 1998: Cerebrovascular complications of intra-arterial peripheral vascular thrombolytic therapy. Stroke 29(1): 304
Hinchey, J.A.; Sila, C.A. 1997: Cerebrovascular complications of rheumatic disease. Rheumatic Diseases Clinics of North America 23(2): 293-316
Strandgaard, S.; Paulson, O.B. 1994: Cerebrovascular consequences of hypertension. Lancet 344(8921): 519-521
Busija, D.W.; Leffler, C.W. 1989: Cerebrovascular consequences of intracranial blood in piglets. FASEB Journal 3(4): A1166
Moore, S.A.; Yoder, E.J.; Rich, G. 1997: Cerebrovascular cyclooxygenase-2 expression is regulated by pro- and anti-inflammatory cytokines. Society for Neuroscience Abstracts 23(1-2): 1166
Moore, S.A.; Yoder, E.J.; Campbell, I.; Murphy, S. 1998: Cerebrovascular cyclooxygenase-2 is induced by activated astrocytes. Society for Neuroscience Abstracts 24(1-2): 1311
Kalaria, R.N. 1997: Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease. Annals of the new York Academy of Sciences 826: 263-271
Madden, K.P.; Rolak, L.A. 1997: Cerebrovascular disease. Civetta, Journal M Author, Taylor, R W Author, Kirby, R R Author Critical care, Third edition 1989-2003
Mishra, S.K.; Furdik, V.J.; Menon, N.K.; Van Lancker, D. 1994: Cerebrovascular disease The commonest neurological malady among US Presidents. Neurology 44(4 Suppl 2): A148-A149
Munari, L.M.; Porta, M. 1990: Cerebrovascular disease. a rational approach to diagnostic protocols. Rays 15(2): 165-178
Meyer, J.S.; Terayama, Y.; Konno, K.; Akiyama, H.; Mortel, K.F.; Margishvili, G.M.; Wills, P.M. 1997: Cerebrovascular disease alters the symptomatic course of migraine. Journal of the Neurological Sciences 150(Suppl ): S35
Parra Medina, D.M.; Kenney, E.; Elder, J.P. 1993: Cerebrovascular disease and smoking. Molgaard, C A Neuroepidemiology: Theory and method: 165-179
Wong, M.C.; Giuliani, M.J.; Haley, E.C. 1990: Cerebrovascular disease and stroke in women. Cardiology 77(Suppl 2): 80-90
Bwala, S.A. 1990: Cerebrovascular disease antiplatelet therapy vs vascular surgery. Saudi Medical Journal 11(2): 83-86
Feigin, V.L.; Wiebers, D.O.; Nikitin, Y.P.; O'fallon, W.M.; Whisnant, J.P. 1995: Cerebrovascular disease epidemiology in Novosibirsk, Russia. Stroke 26(1): 159
Kay, R. 1993: Cerebrovascular disease in Hong Kong. Journal of the Hong Kong Medical Association 45(1): 3-6
Ross, G.W.; Hardman, J.; Petrovitch, H.; Masaki, K.; Blaisdell, J.; Terashita, S.; White, L. 1995: Cerebrovascular disease in an unselected autopsy series of elderly Japanese-American men. Neurology 45(4 Suppl 4): A460
Bernaudin, F.; Verlhac, S.; Brugieres, P.; Ovetchkine, P.; Gaston, A.; Reinert, P. 1996: Cerebrovascular disease in children with sickle cell disease Single center pilot study using transcranial Doppler ANS cMRI, correlation with conventional angiography. Blood 88(10 Suppl 1 Part 1-2): 13A
Kawamura, M.; Fujimoto, S.; Hisanaga, S.; Yamamoto, Y.; Eto, T.; Okuda, S. 1996: Cerebrovascular disease in chronic hemodialysis patients Incidence, outcome and risk factors. Journal of the American Society of Nephrology 7(9): 1486
Blumenthal, H.T.; Premachandra, B.N. 1992: Cerebrovascular disease in dementia. Morley, J E , Et Al (Ed ) Memory Function And Aging-Related Disorders; Symposium, September 17-19, 1990 Xv+333p Springer Publishing Co , Inc : New York, New York, Usa Illus 131-151
Sirajul, H.; Khan, A.R.; Ahmed, T.; Haque, A. 1997: Cerebrovascular disease in diabetics An experience at BIRDEM Hospital. Diabetologia 40(Suppl 1): A460
Tsuruta, K.; Kawabata, N.; Narita, M.; Maeda, K. 1991: Cerebrovascular disease in hemodialysis patients. Blood Purification 9(1): 20-21
Bajwa, Z.H.; Libman, R.; Lipton, R.B.; Rosenbaum, D.; Klomowski, E. 1991: Cerebrovascular disease in patients with hiv. Neurology 41(3 Suppl 1): 295
Hung, T.P. 1993: Cerebrovascular disease in the Taiwan area: past, present and future. Journal of the Formosan Medical Association 92(Suppl 3): S103-S111
Grotta, J. 1997: Cerebrovascular disease in young patients. Thrombosis and Haemostasis 78(1): 13-23
Detwiler, Paul W.; De Los Reyes, R.A. 1996: Cerebrovascular disease of uncertain etiology and uncommon causes of stroke. Tindall, G T, Cooper, P R, Barrow, D L The practice of neurosurgery, vols 1-3 1867-1898
Leno, C.; Combarros, O.; Polo, J.M.; Merino, J.; Pascual, J.; Berciano, J. 1990: Cerebrovascular disease of young adults in cantabria spain a prospective study. Journal of Neurology 237(Suppl 1): S40
Munari, L.M.; Porta, M. 1990: Cerebrovascular disease: pathophysiology and clinical aspects. Rays 15(2): 153-164
Herholz, K.; Heiss, W.D. 1989: Cerebrovascular disease: use of fluorodeoxyglucose. Seminars in Neurology 9(4): 293-300
Zikic, M.; Kopitovic, A.; Todorovski, Z.; Jerkovic, M. 1997: Cerebrovascular disease, heredity, age and sex. Journal of the Neurological Sciences 150(Suppl ): S224
Luengo, A.; Becerra, A.; Colas, J.; Ramos, F.; Conde, M. 1997: Cerebrovascular diseases and levels of Lpa. Journal of the Neurological Sciences 150(Suppl ): S281
Yoon, C.; Yoon, B.; Roh, J. 1997: Cerebrovascular diseases in Takayasus arteritis. Journal of the Neurological Sciences 150(Suppl ): S286
Velkey, I. 1993: Cerebrovascular diseases in childhood. Orvoskepzes 68(2): 131-138
Zanferrari, C.; Lavados, P.M.; Hurko, O.; Oppenheimer, S.M.; Wityk, R.J. 1998: Cerebrovascular diseases in patients with Marfan syndrome A retrospective study. Stroke 29(1): 314
Hennerici, M.; Mess, W.; Rautenberg, W. 1991: Cerebrovascular diseases signs syndromes and follow up. Acta Medica Austriaca 18(2): 34, 36-38
Hirsch, R.; Scaff, M. 1991: Cerebrovascular disorders. Revista Paulista de Medicina 109(1): 27-33
Pizova, N.V. 2008: Cerebrovascular disorders and central hemodynamics of Takayasu disease. Zhurnal Nevrologii I Psikhiatrii imeni S S Korsakova (Suppl 22): 77-80
Roach, E.S. 1993: Cerebrovascular disorders and trauma in children. Current Opinion in Pediatrics 5(6): 660-668
Man'kovskii B.N. 1990: Cerebrovascular disorders in diabetes mellitus patients review. Zhurnal Nevropatologii i Psikhiatrii Imeni S S Korsakova 90(7): 123-127
Butler, I.J. 1993: Cerebrovascular disorders of childhood. Journal of Child Neurology 8(3): 197-200
Rodriguez, R.A.; Teixeira, O.H.P. 1997: Cerebrovascular dysautoregulation assessed by transcranial Doppler in children undergoing head-up tilt testing. Pediatrics 100(3 Part 2): 438
Hennerici, M.; Daffertshofer, M.; Diehl, R.R. 1992: Cerebrovascular dysregulation after ischemic stroke. Neurology 42(4 Suppl 3): 426
Zhang, F.; Hsiao, K.K.; Iadecola, C. 1997: Cerebrovascular dysregulation and increased severity of focal ischemia in transgenic mice overexpressing amyloid precursor protein. Stroke 28(1): 261
Iadecola, C.; Zhang, F.; Eckman, C.; Love, S.; Younkin, S.; Hsiao, K.K. 1997: Cerebrovascular dysregulation and increased susceptibility to ischemic brain damage in APP transgenics. Society for Neuroscience Abstracts 23(1-2): 1389
Bobkiewicz Kozlowska, T.; Forjasz Grus, R. 1995: Cerebrovascular effect of the angiotensin converting enzyme inhibitor lisinopril in spontaneously hypertensine rats. Polish Journal of Pharmacology 47(Suppl ): 52
Gleason, C.A.; Robinson, R.; Harris, A.; Traystman, R.J. 1998: Cerebrovascular effects of IV dopamine in fetal sheep. FASEB Journal 12(5): A671
Gleason, C.A.; Robinson, R.; Harris, A.; Traystman, R.J. 1998: Cerebrovascular effects of IV dopamine infusions in preterm and near-term fetal sheep. Journal of Investigative Medicine 46(1): 138A
Gleason, C.A.; O'brien, T.P.; IIda, H.; Traystman, R.J. 1994: Cerebrovascular effects of cocaine injection in fetal, newborn and adult sheep. Pediatric Research 35(4 Part 2): 380A
Barry, D.I.; Brodsgaard, E.; Pedersen, E.V. 1989: Cerebrovascular effects of dilevalol and pindolol in spontaneously hypertensive rats. European Journal of Clinical Investigation 19(2 Part 2): A51
Rudinsky, B.; Hipps, R.; Morgan, S.; Meadow, W. 1997: Cerebrovascular effects of nebulized nitroprusside during hypoxia-induced pulmonary hypertension in piglets. Pediatric Research 41(4 Part 2): 58A
Lam, A.M.; Matta, B.F.; Mayberg, T.S.; Winn, H.R. 1995: Cerebrovascular effects of propofol as a hypotensive agent during cerebral aneurysm surgery. Anesthesiology 83(3A): A181
Pedersen, E.V.; Waldemar, G.; Bobkiewicz, T.; Knudsen, G.M.; Paulson, O.B.; Barry, D.I. 1989: Cerebrovascular effects of the angiotensin converting enzyme inhibitor fosenopril in spontaneously hypertensive rats. European Journal of Clinical Investigation 19(2 Part 2): A51
Rose, P.G. 1996: Cerebrovascular embolization of choriocarcinoma. Obstetrics and Gynecology 88(4 Part 2): 738
Wei, S.C.; Lai, M.L. 1995: Cerebrovascular emergencies: difficulties and errors in diagnosing various stroke types. Gaoxiong Yi Xue Ke Xue Za Zhi 11(5): 282-289
Hommel, M.; Besson, G.; Mémin, B.; Perret, J. 1993: Cerebrovascular emergency centres. Journal of Neuroradiology 20(3): 199-205
Morin, A.M.; Grotke, H.; Davison, S. 1996: Cerebrovascular endothelium and protection from chemical ischemia injury. Journal of Neurochemistry 66(Suppl 1): S99
Schlech, W.F.IIi 1996: Cerebrovascular events in HIV patients The Halifax experience. Clinical and Investigative Medicine 19(4 Suppl): S58
Ammash, N.; Warnes, C.A. 1995: Cerebrovascular events in adult cyanotic congenital heart disease. Circulation 92(8): I516-I517
Ozdemir, O.; Beletsky, V.; Hachinski, V.; Spence, J.David. 2008: Cerebrovascular events on awakening, patent foramen ovale and obstructive sleep apnea syndrome. Journal of the Neurological Sciences 268(1-2): 193-194
Sherriff, S.B. 1996: Cerebrovascular flow dynamics and pathophysiology. Salmasi, A -M, Strano, A Developments in Cardiovascular Medicine; Angiology in practice: 63-72
De Jong, G.I.; De Vos, R.A.; Steur, E.N.; Luiten, P.G. 1997: Cerebrovascular hypoperfusion: a risk factor for Alzheimer's disease? Animal model and postmortem human studies. Annals of the new York Academy of Sciences 826: 56-74
Hanson Painton, O.; Moore, P.; Grammas, P. 1994: Cerebrovascular inhibitor of protein kinase C. FASEB Journal 8(4-5): A85
Blaisdell, F.W. 1991: Cerebrovascular injury neurologic consequences. Journal of Trauma 31(7): 1024
Luiten, P.G.M.; De Jong, G.I.; Stienstra, C.M.; Stuiver, B.T.; Knollema, S.; Korf, J.; Maitenyi, K. 1995: Cerebrovascular insufficiency A risk factor for cognitive decline in aging and Alzheimers disease?. Society for Neuroscience Abstracts 21(1-3): 1725
Mirdzhuraev, E.M. 1998: Cerebrovascular insufficiency in Takayasus disease. Zhurnal Nevrologii i Psikhiatrii Imeni S S Korsakova 98(5): 54-55
Verro, P.; Levine, S.R.; Tietjen, G.E. 1995: Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke 26(1): 160
Pereira, H.A.; Brumback, R.A.; Grammas, P. 1993: Cerebrovascular localization of CAP37 in Alzheimers disease. Society for Neuroscience Abstracts 19(1-3): 692
Wesbey, G.E.; Bergan, J.J.; Moreland, S.I.; Sedwitz, M.M.; Bardin, J.A.; Schmalbrock, P.; Listerud, J. 1992: Cerebrovascular magnetic resonance angiography: a critical verification. Journal of Vascular Surgery 16(4): 619
Belau, C.; Muehler, E. 1991: Cerebrovascular manifestation of chronic neuroborreliosis. Aktuelle Neurologie 18(2): 65-68
SumanSarkar; PrithwisBhattacharya; AnilPaswan 2008: Cerebrovascular manifestations and alteration of coagulation profile in scorpion sting a case series. Indian Journal Of Critical Care Medicine: 1, 15-17
Samuels, M.A.; Thalinger, K. 1991: Cerebrovascular manifestations of selected hematologic diseases. Seminars in Neurology 11(4): 411-418
Dauphin, F.; Hamel, E. 1990: Cerebrovascular muscarinic constriction is mediated by m 1 receptors coupled to phosphoinositide pi turnover. Society for Neuroscience Abstracts 16(1): 202
Wilms, G.; Casaer, P.; Alliet, P.; Demaerel, P.; Smet, M.; Baert, A.L. 1990: Cerebrovascular occlusive complications in osteopetrosis major. Neuroradiology 32(6): 511-513
Rose, J.E. 1991: Cerebrovascular occlusive disease. Grossman, R G (Ed ) Principles Of Neurosurgery Xi+484p Raven Press: New York, New York, Usa Illus 79-112
Domer, F.; Alexander, B.; Milner, P.; Bodin, P.; Burnstock, G. 1992: Cerebrovascular perfusion of the rabbit brain a method that permits evaluation of compounds in effluent samples. Journal of Physiology (Cambridge) 452: 323P
Nag, S.; Young, L. 1990: Cerebrovascular permeability in acute hypertension: effect of flunarizine. Acta Neurochirurgica. Supplementum 51: 344-345
Lewis, S.B.; Piper, I.R.; Reilly, P.L. 1995: Cerebrovascular pressure transmission analysis An indicator of autoregulatory tone. Journal of Neurotrauma 12(3): 461
Lewis, S.B. 1998: Cerebrovascular pressure transmission analysis as a guide to the pathophysiology of raised intracranial pressure. Clinical and Experimental Pharmacology and Physiology 25(11): 947-950
Modanlou, H.D.; Beharry, K.; Bottoli, I.; Norris, K.; Ling, E.; Noya, F.; Aranda, J.V. 1994: Cerebrovascular prostaglandin concentrations during hypotension and hypertension in neonatal groups B streptococcal meningitis. Pediatric Research 35(4 Part 2): 301A
Mertineit, C.; Noya, F.; Ling, E.; Papageorgiou, A.; Aranda, J.V. 1996: Cerebrovascular prostanoid production in neonatal group B streptococcal meningitis. Pediatric Research 39(4 Part 2): 299A
Wahl, M.; Lauritzen, M.; Schilling, L. 1990: Cerebrovascular reactivity after spreading depression. Hammersen, F And K Messmer (Ed ) Progress in Applied Microcirculation, Vol 16 Cerebral Microcirculation; 8th Bodensee Symposium on Microcirculation, Konstanz/Bodensee, West Germany, October 14-16, 1988 X+102p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 89-96
Ceravolo, G.; Minciotti, P.; Orlandini, M.; Provinciali, L. 1990: Cerebrovascular reactivity assessment by means of transcranial doppler sonography in patients affected by carotid occlusion. Journal of Neurology 237(Suppl 1): S22
Wallasch T M.; Reinecke, M. 1991: Cerebrovascular reactivity during valsalva test in migraine. Olesen, J (Ed ) Frontiers in Headache Research, Vol 1 Migraine And Other Headaches: The Vascular Mechanisms Xxv+358p Raven Press: New York, New York, Usa Illus 279-282
Pourcyrous, M.; Bada, H.; Korones, S.; Leffler, C. 1992: Cerebrovascular reactivity following prolonged asphyxia in newborn pigs. FASEB Journal 6(5): A1740
Pourcyrous, M.; Shibata, M.; Bada, H.S.; Korones, S.B.; Leffler, C.W. 1994: Cerebrovascular reactivity following recovery from metabolic acidosis in newborn pigs. Pediatric Research 35(4 Part 2): 249A
Rao, N.S.; Chari, C. 1989: Cerebrovascular reactivity in arteriovenous malformation a transcranial doppler study. Neurology 39(3 Suppl 1): 306
Hajak, G.; Klingelhoefer, J.; Schulz Varszegi, M.; Matzander, G.; Sander, D.; Conrad, B.; Ruether, E. 1993: Cerebrovascular reactivity in sleep. Pharmacopsychiatry 26(5): 157
Pelligrino, D.A.; Lipa, M.D.; Albrecht, R.F. 1990: Cerebrovascular reactivity in the diabetic rat. Anesthesiology 73(3A): 748
Hasui, K.; Kiyomoto, H.; Aki, Y.; Tamaki, T.; Iwao, H.; Abe, Y. 1991: Cerebrovascular reactivity to selective serotonin receptor agonists following experimental subarachnoid hemorrhage. Japanese Journal of Pharmacology 55(Suppl 1): 411P
Micieli, G.; Bosone, D.; Cavallini, A.; Poli, M.; Roatta, S.; Passatore, M.; Nappi, G. 1997: Cerebrovascular regulation and risk for stroke in diabetic patients. Journal of the Neurological Sciences 150(Suppl ): S13
Piepgras, A.; Leinsinger, G.; Schmiedek, P. 1994: Cerebrovascular reserve capacity in AVM patients. Pasqualin, A, Da Pian, R New trends in management of cerebro-vascular malformations 350-351
Leinsinger, G.; Schmiedek, P.; Einhaeupl, K.; Piepgras, A.; Kreisig, T.; Kirsch, C.M. 1992: Cerebrovascular reserve capacity in the longterm follow up after extra intracranial arterial bypass surgery. European Journal of Nuclear Medicine 19(8): 732
Belfort, M.; Saade, G.; Yared, M.; Cruz, A.; Lang, A.; Kramer, W.; Kirshon, B.; Moise, K.Jr 1995: Cerebrovascular resistance in preeclampsia The middle cerebral artery distribution responds differently than other regions of the brain. American Journal of Obstetrics and Gynecology 172(1 Part 2): 382
Von Kummer, R.; Haag, P.; Stingele, R.; Berger, C.; Back, T. 1993: Cerebrovascular response to hemodilution and carbon monoxide inhalation in normotensive and hypotensive non-ischemic cats. Stroke 24(1): 167
Whitelaw, A.; Karlsen, B.; Haaland, K.; Steen, P.A.; Thoresen, M. 1990: Cerebrovascular response to hypocapnia in hypotensive newborn piglets. Pediatric Research 28(3): 278
Reinstrup, P.; Messeter, K. 1994: Cerebrovascular response to nitrous oxide. Acta Anaesthesiologica Scandinavica 38(8): 761-762
Heckmann, J.G.; Hilz, M.J.; Katalinic, A.; Marthol, H.; Mueck Weymann, M.; Neundoerfer, B. 1997: Cerebrovascular response to stress induced blood pressure increase in migraine patients with and without aura. Journal of the Autonomic Nervous System 65(2-3): 111
Anwar, M.; Agarwal, R.; Weiss, H.R.; Sinha, A.K. 1993: Cerebrovascular responses to dorsal raphe stimulation. FASEB Journal 7(3-4): A336
Werner, C.; Kochs, E. 1997: Cerebrovascular responses to general anesthesia and the modern neuroanesthetic. Batjer, H H Cerebrovascular disease: 117-126
Yamamoto, S.; Nishizawa, S.; Uemura, K. 1994: Cerebrovascular responses to hypercapnia and hypertension after subarachnoid hemorrhage in rats. Society for Neuroscience Abstracts 20(1-2): 1761
Nemoto, E.M.; Yonas, H.; Kaufmann, A.; Jungreis, C.; Klementavicius, R. 1996: Cerebrovascular responses to vasopressors before and after subarachnoid hemorrhage in monkeys assessed by Xe/CT. Acta Neurologica Scandinavica 93(Suppl 166): 129-130
Kuwabara, Y.; Ichiya, Y.; Otsuka, M.; Yoshikai, T.; Fukumura, T.; Masuda, K. 1990: Cerebrovascular responsiveness to hypercapnia in senile dementia of alzheimer type and vascular dementia of binswanger type a positron emission tomography study. Journal of Nuclear Medicine 32(5 Suppl): 1079
Torbati, D.; Carey, M.E.; Davidson, J.F. 1990: Cerebrovascular responsiveness to hyperoxic hypercapnia after brain missile wounding bmw in pentobarbital anesthetized cats. Society for Neuroscience Abstracts 16(1): 741
Kelly, P.A.T.; Fouyas, I.P.; Ritchie, I.M.; Whittle, I.R. 1995: Cerebrovascular responsiveness to nitric oxide synthase inhibition in spontaneously diabetic rats. British Journal of Pharmacology 116(Proceedings Suppl ): 191P
Rao, R.; Rosati, A.; Liberini, P.; Gipponi, S.; Venturelli, E.; Sapia, E.; Ambrosi, C.; Padovani, A. 2008: Cerebrovascular risk factors and MRi abnormalities in migraine. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 29(Suppl 1): S144-S145
Luijendijk, H.J.; Stricker, B.H.; Hofman, A.; Witteman, J.C.M.; Tiemeier, H. 2008: Cerebrovascular risk factors and incident depression in community-dwelling elderly. Acta Psychiatrica Scandinavica 118(2): 139-148
Geocadin, R.G.; Qureshi, A.I.; Suarez, J.I.; Parekh, P.D.; Tamargo, R.J.; Bhardwaj, A.; Ulatowski, J.A. 1998: Cerebrovascular risk factors and the risk of symptomatic cerebral vasospasms following subrachnoid hemorrhage. Neurology 50(4 Suppl 4): A412
Kaminow, L.C.; Bevan, J.A. 1989: Cerebrovascular selective calcium channel antagonist ta 30 90 ameliorates ischemic and vascular changes in rabbit middle cerebral artery mca occlusion. Stroke 20(1): 143
Pearce, W.J.; Harder, D.R. 1996: Cerebrovascular smooth muscle and endothelium. Mraovitch, S, Sercombe, R Neurophysiological basis of cerebral blood flow control: An introduction 145-175
Prior, R.; Urmoneit, B.; Prikulis, I.; Wihl, G.; D'urso, D.; Frank, R.; Heeren, J.; Beisiegel, U. 1997: Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway Pathogenetic relevance in cerebral amyloid angiopathy. Society for Neuroscience Abstracts 23(1-2): 2235
Ardinger, R.H.; Goertz, K.K.; Mattioli, L.F. 1994: Cerebrovascular stenoses with cerebral infarction in a child with Williams syndrome. American Journal of Medical Genetics 51(3): 200-202
Deutsch, G.; Mountz, J.M.; Liu, H.G.; San Pedro, E.C. 1996: Cerebrovascular stress tests in parenchymal versus vascular cerebral disease. Journal of Nuclear Medicine 37(5 Suppl): 88P
Smirnov, Y.K.; Shishov, A.S. 1991: Cerebrovascular systems in ophthalmic zoster reconvalescents. Zhurnal Nevropatologii i Psikhiatrii Imeni S S Korsakova 91(10): 117-121
Wagerle, L.C.; Busija, D.W. 1989: Cerebrovascular txa 2 pg endoperoxide tp receptors and cholinergic vascular regulation in newborn piglets. Pediatric Research 25(4 Part 2): 73A
Lewis, D.H.; Newell, D.W.; Byrd, S.; Douville, C.; Winn, H.R. 1993: Cerebrovascular vasodilatory tests Diamox SPECT and carbon dioxide TCD. Journal of Nuclear Medicine 34(5 Suppl): 62P-63P
Pickard, J.D.; Czosnyka, M.; Smielewski, P.; Piechnik, S. 1998: Cerebrovascular volume reactivity in head injury. Journal of Neurotrauma 15(1): 12
Clark, R.S.B.; Kochanek, P.M.; Brookens, M.; .Schiding, J.K.; Turner, D.S.; Watkins, S.C. 1994: Cerebrovascular, inflammatory cell and neuronal inducible nitric oxide synthase expression after trauma in immature rats. Pediatric Research 37(4 Part 2): 43A
Luiten, P.G.; de Jong, G.I.; Schuurman, T. 1994: Cerebrovascular, neuronal, and behavioral effects of long-term Ca2+ channel blockade in aging normotensive and hypertensive rat strains. Annals of the new York Academy of Sciences 747: 431-451
Fillion, H.; Pera, M.H.; Hseine, A. 1991: Cerebrovasodilatation activity and platelet and aggregation of allenyl derivatives. Die Pharmazie 46(2): 148
Nakai, M.; Maeda, M. 1993: Cerebrovasodilator action of the periaqueductal grey matter mediated by the central cholinergic nerve. Neuroscience Research Suppl 1993(18): S213
Zhang, A.; Altura, B.T.; Altura, B.M. 1997: Cerebrovasospasm induced by activation of protein kinase C in isolated canine basilar arteries in the presence and absence of calcium. FASEB Journal 11(3): A262
Gorbea Oppliger, V.J.; Petit, R.; Melaragno, M.G.; Potter, G.S.; Fink, G.D. 1994: Cerebroventricular infusion of an AT-1 angiotensin does not influence chronic angiotensin induced hypertension. FASEB Journal 8(4-5): A881
Zhou, D.; Schneider, J.E.; Ji, H.; Friedman, M.I. 1998: Cerebroventricular leptin affects estrous cycles indirectly by increasing metabolic fuel oxidation. Society for Neuroscience Abstracts 24(1-2): 619
Correia, M.L.G.; Morgan, D.A.; Sivitz, W.S.; Mark, A.L.; Haynes, W.G. 1998: Cerebroventricular leptin prevents hypotension caused by weight loss. Circulation 98(17): I336
Goetsch, T.; Moermann, W.; Krejci, I.; Lutz, F. 1990: Cerec ceramic inlays clinically assessed using modified usphs criteria. Journal of Dental Research 69(Special Issue): 162
SaleseSilva,J.S. 2008: Ceremonial and protocol on the defense of monographs for undergraduation courses a rite of passage. Turismo E Sociedade: 1, 43-52
Freeman, G.L. 1991: Ceremonials associated hypersensitivity in the native americans. Annals of Allergy 66(1): 92
Anonymous 2008: Cereophonius hrachycentrus bivittatus Thorell, 1877 currently Orohothriurus bivittatus; Arachnida, Scorpiones proposed replacement of the holotype by the designation of a neotype not accepted. Bulletin of Zoological Nomenclature 65(Part 1): 69-70
Mackic, J.B.; Stins, M.F.; Jovanovic, S.; Bartus, R.T.; Zlokovic, B.V. 1998: Cereport transiently increases inulin permeability across human brain microvascular endothelial cell monolayer. Society for Neuroscience Abstracts 24(1-2): 266
Dean, R.L.; Emerich, D.F.; Marsh, J.; Hasler, B.; Agostino, M.; Lafreniere, D.; Snodgrass, P.; Xiong, H.; Bartus, R.T. 1998: CereportTM increases uptake of carboplatin in a rat model of cerebral metastatic tumors. Society for Neuroscience Abstracts 24(1-2): 2164
Cerda, G.M. 1991: Ceresium unicolor unicolor new record fabr coleoptera cerambycidae collected on easter island south pacific ocean. Acta Entomologica Chilena 16: 271-272
Edwards, K.; (Usa), C. 1102 008 Study Group 1996: Cerestat in the treatment of acute ischemic stroke Results of a phase II trial. Neurology 46(2 Suppl): A424
Wu, Z.; Jin, R.; Liu, Y.; Wang, H. 2008: Ceria modified MnOx/TiO2 as a superior catalyst for NO reduction with NH3 at low-temperature. Catalysis Communications 9(13): 2217-2220
Molodtsova, T.N.; Malakhov, V.V. 1995: Cerianthus lloydii from the volcanic ecosystem of Kraternaya Bay 1 Morphology and anatomy of adult polyps, geographic distribution. Zoologicheskii Zhurnal 74(10): 5-17
Hwu, J.R.; Jain, M.L.; Tsay, S.C.; Hakimelahi, G.H. 1996: Ceric ammonium nitrate in the deprotection of tert-butoxycarbonyl group. Tetrahedron Letters 37(12): 2035-2038
M.Y.Rong, Zhu Dai Shun 1995: Ceric sulfate method for determination of nitrendipine tablets. Zhongguo Yiyao Gongye Zazhi 26(9): 410-411
Anon 1991: Cericlamine hydrochloride antidepressant 5 ht uptake inhibitor. Drugs of the Future 16(4): 301-304
Eberlein, F. 1991: Cerinthe minor juniperus sabina and sedum dasyphyllum in the berchtesgaden countryside. Berichte der Bayerischen Botanischen Gesellschaft zur Erforschung der Heimischen Flora 62: 231-233
Voigt, E. 1994: Ceripora-like features in idmoneiform cyclostomate bryozoans. Hayward, P J, Ryland, J S, Taylor, P D Biology and palaeobiology of bryozoans 197-200
Anonymous 1996: Cerisier Bleu, Citronnelle. Bois et Forets des Tropiques 1996(249): 63-66
Matsuoka, A.; Ohie, Y.; Hirobe, T.; Horiguchi, T.; Shikama, K. 1995: Cerithidea myoglobin A dimer-monomer conversion coupled with the heme oxidation. Zoological Science 12(Suppl ): 50
Sugiyama, T. 1995: Cerium in organic reactions Construction of 2-isoxazoline ring mediated by ammonium cerium nitrate. Applied Organometallic Chemistry 9(5-6): 399-411
Li, Y.; Qi, D.; Deng, C.; Yang, P.; Zhang, X. 2008: Cerium ion-chelated magnetic silica microspheres for enrichment and direct determination of phosphopeptides by matrix-assisted laser desorption ionization mass spectrometry. Journal of Proteome Research 7(4): 1767-1777
Sumaoka, J.; Kajimura, A.; Imai, T.; Ohno, M.; Komiyama, M. 1998: Cerium lanthanide /dextran ternary solutions for efficient and homogeneous DNA hydrolysis. Nucleosides and Nucleotides 17(1-3): 613-623
Van Noorden, C.J.; Frederiks, W.M. 1993: Cerium methods for light and electron microscopical histochemistry. Journal of Microscopy 171(Part 1): 3-16
Holzgrabe, U.; Reinhardt, J.; Stoll, E. 1993: Cerium oxidations, Part IX Cyclization of diethyl 4-phenylbutane-1,1-dicarboxylate. Archiv der Pharmazie (Weinheim) 326(12): 985-987
Ueda, R.; Konno, N.; Nakatani, M.; Iwata, T.; Katagiri, T. 1998: Cerium probe studies of production of hydrogen peroxide in situ in rat heart cells during hypoxia-reoxygenation. Journal of Molecular and Cellular Cardiology 30(6): A13
Chandran, S.; Chitra, S.; Sasidhar, P.; Lal, K.B.; Amalraj, R.V. 1991: Cerium uptake by cell immobilized actinomycetes. Indian Journal of Environmental Health 33(4): 519-522
Zweit, J.; Goodall, R.; Babich, J.W.; Sharm, H.L.; Ott, R.J. 1993: Cerium-134/lanthanum-134, a new radionuclide generator system for positron emission tomography. Journal of Labelled Compounds and Radiopharmaceuticals 32: 480-481
Staneva Dobrovski, L. 1992: Cerium-based cytochemistry of thiamine pyrophosphate in the cyclic rat endometrium. Graumann, W Progress in Histochemistry and Cytochemistry; Histochemistry of receptors: 290-291
McClellan, K.J.; Wiseman, L.R.; McTavish, D. 1998: Cerivastatin. Drugs 55(3): 415
Kuhlmann, J.; Mueck, W.; Bischoff, H.; Von Keutz, E.; Llewellyn, M. 1998: Cerivastatin A novel HMG-CoA reductase inhibitor. Cardiovascular Drug Reviews 16(3): 236-263
Renders, L.; Mayer Kadner, I.; Koch, C.; Burkhardt, K.; Veelken, R.; Schmieder, R.; Hauser, I.A. 1998: Cerivastatin and atorvastatin Efficacy, safety and drug-interaction of the new HMG-CoA reductase inhibitors in renal transplant recipients. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 694A
Insull, W.; Stein, E.; Whalen, E.; Ripa, S. 1997: Cerivastatin, a new potent HMG-CoA reductase inhibitor Efficacy and tolerability in primary hypercholesterolemia. Journal of the American College of Cardiology 29(2 Suppl A): 46A
Yang, Z.; Tanner, F.C.; Lachat, M.; Luescher, T.F. 1998: Cerivastatin, and HMG-CoA reductase inhibitor, strongly inhibits human vascular smooth muscle cell growth Effects on cell cycle regulators. European Heart Journal 19(ABST Suppl ): 615
McLean, J.W. 1990: Cermet cements. Journal of the American Dental Association 120(1): 43-47
Polyakova, V.A.; Serikova, L.G.; Shushpanova, T.I.; Berezko, A.V. 1991: Cermet filters for fine purification of drug solutions. Khimiko-Farmatsevticheskii Zhurnal 25(11): 71-72
Lill, K.; Wimmer, W. 1996: Cernuella neglecta from three localities in Eastern Lower Saxony. Mitteilungen der Deutschen Malakozoologischen Gesellschaft 1996(58): 17-21
Puente, A.I.; Prieto, C.E. 1991: Cernuella neglecta in the Iberian Peninsula. Iberus 8(2): 31-37, 1988
Fasanella, A.; Lia, R.; Giangaspero, A. 1995: Cernuella virgata intermediate snail host for Dicrocoelium dendriticum in apulia region, Italy. Parasite 2(3): 331-333
Lambdin, P. 1998: Cerococcus michaeli A new species of false pit scale from New Zealand. Entomological News 109(5): 297-300
Bland, K.P. 1993: Cerodontha luzulae A species new to Britain. Entomologist's Gazette 44(4): 271-273
Porta, E.A. 1991: Ceroid and lipofuscin in the liver history and its state of the art. Kitani, K (Ed ) International Congress Series, 940 Liver And Aging - 1990: Proceedings Of The Fourth Tokyo Symposium on Liver And Aging, Tokyo, Japan, August 15-17, 1990 Xvi+364p Elsevier Science Publishers B V : Amsterdam, Netherlands; (Dist in The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York) Illus 89-108
Malhotra, R.; Rao, S.; Herman, L. 1993: Ceroid granuloma of the skin An unusual pigmented lesion. Journal of Cutaneous Pathology 20(6): 555
Al Nafussi, A.I.; Hughes, D.; Rebello, G. 1992: Ceroid granuloma of the uterine cervix. Histopathology 21(3): 282-284
Fitzmaurice, M.; Ratliff, N.B. 1990: Ceroid in atherosclerotic aortocoronary saphenous vein bypass grafts svg. Laboratory Investigation 62(1): 33A
Kitani, K.; Ohta, M.; Ivy, G.O.; Kanai, S. 1989: Ceroid lipofuscin in kidneys of young rats and mice induced by leupeptin is similar to age pigments. Age 12(4): 148-149
Cameron, C.H.S.; Allen, I.V.; Higginson, J.D.S.; Mirakhur, M.; Patterson, V.H. 1991: Ceroid lipofuscinosis associated with retinitis pigmentosa and cardiomyopathy a case report. Journal of Pathology 164(4): 364A
Taylor, R.M.; Farrow, B.R. 1992: Ceroid lipofuscinosis in the border collie dog: retinal lesions in an animal model of juvenile Batten disease. American Journal of Medical Genetics 42(4): 622-627
Mitchinson, M.J.; Ball, R.Y.; Carpenter, K.H.; Enright, J.H.; Brabbs, C.E. 1990: Ceroid, macrophages and atherosclerosis. Biochemical Society Transactions 18(6): 1066-1069
Terman, A.; Brunk, U.T. 1998: Ceroid/lipofuscin formation in cultured human fibroblasts: the role of oxidative stress and lysosomal proteolysis. Mechanisms of Ageing and Development 104(3): 277-291
Patil, N.; Almeida, M.R. 1996: Ceropegia bulbosa var lushii Hook F A new food plant for plain tiger butterfly Danaus chrysippus. Journal of the Bombay Natural History Society 93(3): 600
Nicholas, A. 1993: Ceropegia decidua ssp pretoriensis Transvaal Asclepiadaceae. Flowering Plants of Africa 52(2)
Kondo,T. 2008: Ceroplastes rubens Maskell , a new coccid record for Colombia. Boletin Del Museo De Entomologia De La Universidad Del Valle (bheuv): 1, 66-68
Bowman, R.M. 1989: Certain 1 2 benzisoxazole derivatives us patent 4859691 august 22 1989. Official Gazette of the United States Patent and Trademark Office Patents 1105(4): 2608
Lee, D.L. 1989: Certain 1 3 diphenyl 1 3 propanediones us patent 4795489 january 3 1989. Official Gazette of the United States Patent and Trademark Office Patents 1098(1): 307
Fukaya, C.; Ashimori, A.; Ono, T.; Yokoyama, K. 1989: Certain 1 4 dihydro 2 6 dilower alkyl 4 mono substituted pyridyl useful for treating coronary artery or cerebral artery disease us patent 4849429 july 18 1989. Official Gazette of the United States Patent and Trademark Office Patents 1104(3): 1995
Sauerberg, P.; Olesen, P. 1996: Certain 1,2,5-thiadiazol-4-yl-1-azabicyclo 321octane derivatives and their pharmaceutical uses. Official Gazette of the United States Patent and Trademark Office Patents 1192(2): 1260
Oriek, B.S.; Wyman, P.A.; Wadsworth, H.J. 1996: Certain 1-azabicyclo221heptanes and 1-azabicyclo222octanes. Official Gazette of the United States Patent and Trademark Office Patents 1188(5): 3715
Alker, D.; Cross, P.E.; Kemp, J.E.G. 1995: Certain 1-azabicyclo221heptanes useful as muscarinic receptor antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1172(2): 1139
Sauerberrg, P.; Olesen, P.H. 1996: Certain 1-azabicyclo331nonene derivatives and their pharmacological uses. Official Gazette of the United States Patent and Trademark Office Patents 1192(4): 2886-2887
Fisher, A.; Segall, Y.; Shirin, E.; Karton, Y.; Meshulam, H. 1995: Certain 1-methyl-piperidine-4-spiro-4- and corresponding -. Official Gazette of the United States Patent and Trademark Office Patents 1173(3): 1981
Carter, C.G. 1989: Certain 2 2 substituted benzoyl 1 3 cyclohexanediones us patent 4806146 february 21 1989. Official Gazette of the United States Patent and Trademark Office Patents 1099(3): 1377
Carter, C.G.; Lee, D.L.; Michaely, W.J. 1989: Certain 2 2 substituted benzoyl 1 3 cyclohexanediones us patent 4853028 august 1 1989. Official Gazette of the United States Patent and Trademark Office Patents 1105(1): 301
Knudsen, C.G. 1989: Certain 2 2 substituted benzoyl 4 substituted imino oximino or carbonyl 1 3 cyclohexanediones us patent 4838932 june 13 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(2): 1130-1131
Lee, D.L. 1989: Certain 2 2 substituted benzoyl 4 substituted oxy or substituted thio 1 3 cyclohexanediones us patent 4808214 february 28 1989. Official Gazette of the United States Patent and Trademark Office Patents 1099(4): 2080
Cox, D.; Hall, D.E.; Ingall, A.H.; Suschitzky, J.L. 1989: Certain 2 pyridinylphenylsulfinylbenzoxazoles the corresponding benzothiazoles or benzimidazoles having anti inflammatory or gastric acid secretion inhibition activity us patent 4851419 july 25 1989. Official Gazette of the United States Patent and Trademark Office Patents 1104(4): 2692-2693
Lee, D.L.; Michaely, W.J. 1989: Certain 2 substituted benzoyl 5 substituted or unsubstituted phenyl 1 3 cyclohexanediones as herbicides us patent 4806152 february 21 1989. Official Gazette of the United States Patent and Trademark Office Patents 1099(3): 1379
Moldt, P.; Scheel Krueger, J.; Jensen, L.H. 1994: Certain 2,3-diphenyl-2- tropanes useful as dopamide reuptake inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1168(5): 3336
Miller, A.A.; Nobbs, M.S.; Hyde, R.M.; Leach, M.J. 1996: Certain 2,4-diamino-5- -6-substituted-pyrimidines which are pharmacologically active CNS compounds. Official Gazette of the United States Patent and Trademark Office Patents 1193(4): 2822-2823
Schwenner, E.; Stegelmeier, H.; Kazda, S.; Knorr, A. 1989: Certain 2h benzo a quinolizin 2 ylaminoalkyl esters of 1 4 dihydro 3 5 pyridinedicarboxylates useful for treating circulation disorders us patent 4861782 august 29 1989. Official Gazette of the United States Patent and Trademark Office Patents 1105(5): 3334
Jones, W.D.; Schnettler, R.A.; Dage, R.C. 1989: Certain 3 carboxylate or 3 carbamyl 5 acyl 2 1h pyridinones having cardiotonic properties us patent 4853395 august 1 1989. Official Gazette of the United States Patent and Trademark Office Patents 1105(1): 404
Stoltefuss, J.; Franckowiak, G.; Boeshagen, H.; Bechem, M.; Gross, R.; Hebisch, S.; Huetter, J.; Rounding, H P.; Schramm, M. 1995: Certain 3-formyl-1, 4-dihydropyridines and their pharmaceutical composition and use. Official Gazette of the United States Patent and Trademark Office Patents 1174(5): 3372-3373
Goldmann, S.; Bischoff, H.; Puls, W.; Bender, J.; Petzinna, D.; Schlossmann, K. 1989: Certain 4 thienyldihydropyridines us patent 4801715 january 31 1989. Official Gazette of the United States Patent and Trademark Office Patents 1098(5): 2481
Thurkauf, A.Y.; Hutchison, A.J. 1995: Certain 4-aryl substituted piperazinyl and piperidinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands. Official Gazette of the United States Patent and Trademark Office Patents 1175(4): 2546
Thurkauf, A.; Horvath, R.F.; Yuan, J.; Peterson, J.M. 1997: Certain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligands. Official Gazette of the United States Patent and Trademark Office Patents 1200(2): 1341
Tanker, M.; Tanker, N. 1994: Certain Anatolian plants and their constituents influencing drug disposition. European Journal of Pharmaceutical Sciences 2(1-2): 77-78
Itescu, S.; Ryan, D.; Burke, E.; Mancini, D.; Rose, E.; Reed, E.; Suicu Foca, N.; Michler, R. 1996: Certain HLA-DR types in the donor heart are associated with accelerated coronary artery disease in transplant recipients. Journal of Heart and Lung Transplantation 15(1 Part 2): S92
Empfield, J.R.; Ohnmacht, C.J.; Russell, K.; Trainor, D.A.; Warwick, P.J.Jr 1996: Certain N -3-trifluoro-2-hydroxy-propanamide derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1182(2): 1195
Marescaux, C.; Bernasconi, R.; Schmutz, M.; Frostl, W.; Mickel, S.J. 1995: Certain N-substituted-amino-alkane phosphinic acid derivatives having anti-epileptic properties. Official Gazette of the United States Patent and Trademark Office Patents 1173(3): 1976
Lichtenberger, L.M.; Wang, Z.M.; Romero, J.J.; Barreto, J.C. 1994: Certain NSAIDS chemically associate with surface phospholipids Insight into mechanism and reversal of NSAID-induced gastric injury. Gastroenterology 106(4 Suppl): A125
Kunstmann, E.; Elitok, E.; Epplen, C.; Suerbaum, S.; Peitz, U.; Epplen, J.T.; Schmiegel, W. 1998: Certain TNFA microsatellite alleles are associated with different course of Helicobacter pylori infection. Gastroenterology 114(4 Part 2): A1016
Clough, J.M.; Godfrey, C.R.A.; De, F., P.J.; Hutchings, M.G.; Anthony, V.M. 1995: Certain acrylates having fungicidal activity. Official Gazette of the United States Patent and Trademark Office Patents 1177(1): 342
Parker, D.T. 1998: Certain alpha-substituted arylsulfonamido acetohydroxamic acids. Official Gazette of the United States Patent and Trademark Office Patents 1211(4): 4099
Giger, R.K.A.; Mattes, H. 1996: Certain aminoguanidine compounds, pharmaceutical compositions containing them and their use in treating gastrointestinal motility disorders and disorders associated with cephalic pain. Official Gazette of the United States Patent and Trademark Office Patents 1185(4): 2716-2717
Thurkauf, A.; Hutchison, A. 1997: Certain aminomethyl phenylimidazole derivatives; and 4-aryl substituted piperazinyl and piperidinylmethyl phenylimidazole derivatives; a new class of dopamine receptor subtype ligands. Official Gazette of the United States Patent and Trademark Office Patents 1198(4): 2600
Zasloff, M.; Shinnar, A.; Kinney, W.; Jones, S. 1998: Certain aminosterol compounds and pharmaceutical compositions including these compounds. Official Gazette of the United States Patent and Trademark Office Patents 1217(2): 1681
Kimura, K.; Kise, M.; Morita, I.; Tomita, T.; Tsuda, M. 1989: Certain antihypertensive 1 4 dihydro 6 methyl 5 phosphonic acid 4 aryl 3 carboxylic acid 2 cyano diesters us patent 4857515 august 15 1989. Official Gazette of the United States Patent and Trademark Office Patents 1105(3): 1845
Ward, R.W.; Markwell, R.E.; Hughes, I. 1989: Certain antiinflammatory pyrazolo 4 3 b pyridine 7 amines us patent 4818754 april 4 1989. Official Gazette of the United States Patent and Trademark Office Patents 1101(1): 527
Cao, J.; Vermaas, W.; Govindjee 1991: Certain arginine residues in the d2 polypeptide may stabilize bicarbonate binding in photosystem ii of synechocystis sp pc 6803. Photochemistry and Photobiology 53(Suppl): 121S
Shaw, K.; Hutchison, A. 1998: Certain aryl and crycloalky fused imidazopyrazinediones; a new class of gaba brain receptor ligands. Official Gazette of the United States Patent and Trademark Office Patents 121(4): 4060